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1. Outline and Objectives of this study 
 
Leishmaniasis is a parasitic infectious disease comprised from a variety of syndromes, very 
different the one with the other in their epidemiology, pathogenesis and clinical picture. 
According to the World Health Organization (WHO), leishmaniasis is considered as one of 
the most important parasitic diseases (WHO, 1990). It is endemic in 88 countries in five 
continents with 12 million people afflicted world wide from it and another 350 million living 
at risk of infection. About 1-1.5 million new cases of cutaneous leishmaniasis (CL) and 
500,000 of visceral leishmaniasis (VL), rise per year (Desjeux, 1996). 
 
The disease is attributed to Leishmania, haemoflagellate protozoan parasites of the 
Trypanosomatidae family. In many localities more than one Leishmania species co-exist with 
overlapping animal hosts and vectors. It is a zoonotic disease but it is still not known to what 
extent that affects the epidemiology, transmission and planning of control measures. 
 
During the recent years parallel to the development of techniques based on the genomic 
information of organisms, there is an increased effort to apply this knowledge to the applied 
fields of disease diagnostics. In the course of not many years now, some methods were 
developed for the diagnosis of leishmaniasis based on the genomic information of the 
parasite. Some of them could detect the parasite very successfully, some not and some are still 
standing under question. The aim of this study was the evaluation of PCR methods for 
detection, species identification and determination of genetic variation in L. infantum.  
 
RFLP (restriction fragment length polymorphism) of the ITS (internally transribed spacer), 
and fingerprinting with single arbitrary primers deriving from the core sequence of the phage 
M13, from the intergenic tRNA spacers (T3B) and the simple repeat sequences (GTG) 5 and 
(GACA) 4 (Schönian et al., 1996; Schönian et al., 2000), were applied. Those methods have 
two general goals: first to discriminate if possible between closely related species and 
complexes and second to establish a degree of evolutionary relationships. This leads to the 
construction of molecular evolutionary trees that provide a logical framework to view the 
evolutionary process in these organisms. 36 well characterised Leishmania strains, 21 canine 
isolates from Northern Greece and 9 human isolates went through both those methods.  
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Those isolates that were identified as L. infantum, coming from the whole Mediterranean 
basin, were processed through a PCR-SSCP (polymerase chain reaction-single stranded 
conformation polymorphism) with codominant markers, to search levels of genetic variation 
and heterogeneity among strains of L. infantum. For this 8 sets of codominant primer pairs 
were used and 42 Leishmania donovani complex strains (38 L. infantum, 2 L. chagasi and 2 L. 
donovani). 
 
The 42 Leishmania donovani complex strains and 24 clinical canine samples went also 
through a diagnostic PCR that amplified a 560 bp variable fragment of the ssu rRNA gene 
(Meredith et al., 1993; Osman et al., 1998a), in order to evaluate detection efficiencies also in 
canine samples and clinical speciments. 
 
The results of all procedures combined together exploit and establish even more the situation 
of whether the L. infantum population of the Mediterranean area is a clonal or a recombinant 
one. Previous studies based on non-molecular approaches and techniques have suggested a 
clonal population (Jimenez et al, 1997) of the same dominant clone (MON1).  
 
This work is part of a greater project that is centered in Berlin at the Institute of Microbiology 
and Hygiene, Charité, Berlin and is headed by Dr Gabriele Schönian. This project is under 
work since 1995 and is continued in collaboration with countries where the disease is 
endemic. 
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2. Literature Review 
 
2.1 The genus Leishmania 
 
Leishmania are haemo-flagellate protozoan parasites that belong to the family of 
Trypanosomatidae. They are obligate intracellular parasites that are transmitted to the 
mammalian host by the bites of infected sandflies. On the basis of development in the 
sandflies, the genus Leishmania has been divided into two subgenera. Development of 
organisms belonging to the subgenus Leishmania is restricted to the anterior portion of the 
alimentary tract of the Phlebotomus sandflies (suprapylarian development), whereas 
organisms belonging to the subgenus Viannia develop in the midgut and hindgut of the 
sandflies  Lutzomyia spp. (peripylarian development). Viannia contains the complex of L. 
brasiliensis (L. brasiliensis, L. guyanensis, L. panamensis), L. mexicana, L. amazonensis and 
L.panamensis. The subgenus Leishmania contains the complex L. donovani (L. infantum, L. 
donovani, L. chagashi), L. major, L. tropica and L. aethiopica. There are in total at least 30 
species, of which 12 named and several unnamed infect man (Lainson et al., 1987).  
 
Characterization was originally attempted on geographical and clinical grounds, and later on 
morphology, culture characteristics, biotypes and life cycles, antibody responses to particular 
antigens and lately on genetic analysis. 
 
 
 
2.1.1 Life cycle of Leishmania 
 
Leishmanial parasites are transmitted between long-living (humans, canines) vertebrate hosts 
by short-living Phlebotominae insects (sandflies) (Lewis 1974; Lane 1993). They have a cycle 
of development in the vertebrate host and one in the insect. Sandflies ingest amastigotes while 
sucking blood from the vertebrate host. The amastigotes transform into promastigotes in the 
alimentary tract of the sandflies (Lane 1993). After 4-7 days they migrate to the foregut 
where, they develop into infective metacyclic forms. As the female sandfly has its blood meal, 
necessary before laying on of eggs, the mouthparts of the insect tear tissue and create a tiny 
pool of blood from which they feed and into which metacyclic promastigotes are deposited. 
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Metacyclic promastigotes are inocculated with sandfly saliva, which increases infectivity 
(Titus et al., 1988). The host cells are mononucleated cells e.g. macrophages. It is not 
precisely known how promastigotes enter the macrophages. In the macrophages they 
transform into amastigotes where they multiply and then they are deposited in different parts 
of the body, spleen, liver, bone marrow. 
 
Each Leishmania species has its own biotope with its own geographical distribution zone and 
complex of parasite, reservoir and vector and their particular intimate relationship within this 
setting. In Table 1 a summary of such relationships is presented.  
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Table 1: Major Leishmania species that are of interest to the public health, their reservoir, 
vector and geographical distribution according to WHO (1996). 
 
 
Leishmania 
species 
Vector Reservoir Geographical 
distribution 
Old World    
L. infantum Phlebotomus 
perniciosus, P. ariasi 
Dogs, foxes, jackals Mediterranean basin, 
Middle east, China, 
Central Asia 
 
L. donovani P. argentipes Humans North-east India, 
Bangladesh, Burma 
 
L. donovani P. orientalis, P. 
martini 
Rodents in Sudan,  
canines, humans, 
gerbils 
 
Sudan, Kenya, Horn of 
Africa 
L. major P. papatasi, P. 
duboscqi 
Gerbils (Rhombomys, 
Meriones), Rodents 
(Arvicanthus, Tatera) 
Middle East, North India, 
Pakistan, North Africa, 
Central Asia, Sub-
Saharan savannah, Sudan 
 
L. tropica P. sergenti Humans 
 
Middle East, 
Mediterranean basin, 
Central Asia 
 
L. aethiopica P. longipes, P. pedifer Hyraxes Highlands of Kenya, 
Ethiopia 
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New World 
L. chagasi Lutzomyia longipalpis Foxes, dogs, 
opossums 
Central America, 
Northern South America 
(Brazil, Venezuela, 
Yucatan, Belize, 
Guatemala) 
 
L. brasiliensis Lutzomyia spp., 
Psychodopygus 
wellcomei 
 
Forest rodents, 
peridomestic animals 
Tropical forests of South 
and Central America 
L. guyanensis Lu. umbratilis Sloths (Choleopus), 
arboreal anteaters 
(Tamandua) 
 
Guyana, Surinam, Brazil 
L. panamensis Lu. trapidoi Sloths (Choleopus) Panama, Costa Rica, 
Colombia 
 
L. mexicana Lu.olmeca Forest rodents Yucatan, Belize, 
Guatemala 
 
L. amazonensis Lu. flaviscutellata Forest rodents Tropical forests of South 
America 
 
L. peruviana Lutzomyia spp. Dogs West Andes of Peru, 
Argentine highlands 
 
 
Leishmaniases are normally zoonoses infecting wild animals like rodents, edentates and 
canines. In each transmission cycle there is a restricted number of primary reservoir hosts that 
maintain the cycle. Some times there are secondary hosts as well, that extend the cycle like 
the dogs in L. chagasi and accidental ones that are not important from the view point of 
maintaining the cycle like man in the case of L. major. It has been suggested that acute human 
cases of VL in Africa (not in Europe) are also serving as reservoirs. Nevertheless new 
 6 
epidemiological results on HIV-Leishmania co-infected patients in the Medditeranean area 
and the post-kala-azar dermal leishmaniasis (PKDL) in India and Sudan (WHO, 2000), are 
overthroughing such suggestions. The PKDL is a condition by which man is a reservoir for L. 
donovani (Osman, 1998b).  
 
In the Old World sandfly vectors belong to the genus Phlebotomus and in the New World to 
the genera Lutzomyia and Psychodopygus. The breeding sites of many species are unknown. 
Breeding sites, flying habits, feeding habits, degree of anthropophilia or zoophilia (Lainson, 
1983), efficiency of transmission (Dye, 1992), life span and biting during the night, are some 
of the important determinants of infection, and thus of control measures of the disease as well 
(Lewis et al., 1987). 
 
When the reservoir and the vector share the same habitat like P. papatasi and the gerbil, then 
the risk of human infection becomes high (L. major). Where the habitats are separate but 
partly overlapping, the risk becomes relatively less, like in the case of Lu. umbratilis and L. 
guyanensis (Ashford  et al., 1987). 
 
Man and/or dog are usually infected by the bite of an infected sandfly. VL has been rarely 
transmitted by blood transfusion, by sharing needles (drug abusers) (le Fichoux et al., 1999), 
sexual intercourse (Symmers, 1960), accidental or deliberate inoculation in the laboratory 
(Manson-Bahr et al., 1963), or congenitally (Nyakundi et al., 1988). Cutaneous leishmaniasis 
(CL) has been reported to be transmitted by deliberate scarification as a form of immunisation 
(Gunders, 1987) and through suckling (Marsden et al., 1985). 
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2.2 The diseases of leishmaniases 
Leishmaniasis is not a single disease but a variety of syndromes that differ remarkably with 
one another. The WHO considers leishmaniasis as one of the most important parasitic 
diseases (WHO, 1990). Leishmaniases are endemic in 88 countries on the five continents 
(except Oceania), with a total of 350 million people at risk and 12 million afflicted world-
wide. There are 1-1.5 million new cases of CL and 500 000 of VL per year (Desjeux, 1996).  
 
 
2.2.1 Epidemiology of Leishmaniasis 
 
The epidemiology of leishmaniasis in a given area is directly dependent on the behaviour of 
the human and/or animal population in relation to the cycle of transmission. There is a variety 
of factors that influence the transmission of the disease. Some are the following (for review 
see Kettle, 1995 and Lane, 1993): 
• Proximity of residence to sandfly breeding and resting sites. 
• Type of housing. 
• Occupation. 
• Extent of exposure to sandfly bites. 
• Natural resistance, genetic or acquired. 
• Virulence of the parasite species. 
• Zoonotic or anthroponotic reservoirs. It seems that zoonotic reservoirs are particularly 
stable when wild uncontrolled populations (e.g. rodents) are involved. Up to now it 
seemed that humans are not a reliable agent because of death and treatments except of the 
chronic condition of PKDL. Nevertheless recent reports about asymptomatic infections in 
healthy blood donors in France (le Fichoux, et al., 1999) are adding a new parameter to 
the latter. 
• The vectorial capacity, which is defined as the number of infective bites delivered per 
human per annum (Dye, 1992). 
• Density, seasonality, longevity and flight range of sandfly populations. 
• Anthropophilia or zoophilia of sandflies and degree of it. 
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L. infantum causes VL in the Mediterranean basin, Western Asia and Eastern China in a belt 
between 30° N and 45° N. The infection is enzoonotic in dogs, especially in domestic dogs in 
South Europe, but feral dogs also may serve as a reservoir in the Middle East and foxes in 
South Europe and North Africa (Rioux et al., 1968). Canine infections in the Mediterranean 
basin are often like small outbreaks of disease appearing and disappearing. This may reflect 
the spread of infection by foxes, the availability of breeding sites or reinforcement of the 
disease from old chronic infections. In any case canine infections do not necessarily lead to 
human infections (Pozio et al., 1981). 
In China (Minter, 1987) L. infantum was causing VL in man and dogs but it was quickly 
controlled and the disease was almost eradicated. There are still some infection foci in the 
hills of east and central China. 
 
L. donovani causes anthroponotic VL, or Kala-azar in the Indian subcontinent and in some 
parts of China (Ashford et al., 1987). Man is the only known reservoir especially in areas 
where the presence of PKDL is common. Nevertheless destabilisation of the disease has come 
through famine, malaria and influenza (Dye et al., 1988) and mass spraying of DDT to control 
malaria that effected the sandfly vector. The vector P. argentipes rests in cattle sheds that are 
often closely attached to houses, breeds in organic detritus on the ground and a subpopulation 
of it is anthropophilic (Thakur et al., 1981). 
 
L. donovani causes enzoonotic VL in Sub-Saharan Africa, especially in southern Sudan, 
Ethiopia, Somalia and northern Kenya. In Sudan P. orientalis is the vector and certain rodents 
transmit the infection. In Kenya P. martini has been found carrying the parasite. Infected dogs 
are a rare phenomenon and are not considered to be reservoirs in this case (Mutinga et al., 
1980; Mansour et al., 1970). Rare cases have been reported from Niger, Chad, Central 
African Republic, Zambia, Malawi, Zaire and Angola without much information along with 
it. 
 
L. chagasi causes VL in the New World (Shaw et al., 1987). The main endemic area is 
Northeast Brazil where the vector is Lutzomyia longipalpis and foxes, dogs and opossum were 
found serving as reservoirs. Sporadic cases have been reported from Mexico, Honduras, El 
Salvador, Colombia, Venezuela and Bolivia. 
 
 
L. major is responsible for most zoonotic CL of the Old World. It is endemic in the hot 
semideserts and dry silt valleys of North Africa, Middle East, the Arabian Peninsula, 
Rajasthan in India, Turkmenia, Uzbekistan, Tadjikistan, Kazakhstan, across the west of sub-
Saharan Africa, central Sudan and Northern Kenya. The reservoirs are gerbils, girds and fat 
rats (Arvicanthus, Tatera). Lesions are localized, mainly in harless skin, especially ears, and 
persist throughout the animal's life. P. papatasi is the main vector bur also P. sergenti plays a 
role. Transmission is greatest between April and June. People are at risk in expanding towns, 
new settlements, when entering the desert as hunters, soldiers or tourists (WHO 1990, 1996). 
Epidemics often occur after years of quiescence (Belazzoug, 1982). 
 
L. tropica causes anthroponotic CL in the Old World. It has been reported round the 
Mediterranean basin from Greece eastwards, from Northern Serbia and Romania through 
Turkey, Middle East, West Asia in Afghanistan, Pakistan and India up to New Delhi and on 
the whole of the northern African littoral. Man is the principal reservoir but the parasite has 
been isolated from Rattus rattus in Iraq, and   the skin of dogs in India, Russia and Morocco. 
P. sergenti is the main vector and the P. papatasi secondary. Transmission peaks late 
summer. There have been a few cases of VL by L. tropica in India, Kenya and Saudi Arabia 
(Mebrahtu  et al., 1989) and a few of mucosal leishmaniasis (ML) (Lanotte et al., 1981) 
 
L. aethiopica is responsible for cutaneous leishmaniasis in the highlands of Ethiopia, western 
Kenya and eastern Uganda. The vectors are P. longipes and P. pedifer and the reservoirs are 
the hyraxes Procavia habessinica and Heterohyrax brucei (Ashford et al., 1973). This 
parasite is able to suppress the human immune response and produce the diffuse cutaneous 
leishmaniasis (DCL) and lepromatous cutaneous leishmaniasis (LCL) (Bryceson, 1970).  
 
L. brasiliensis is the most common agent that causes CL and ML (espundia), in Central and 
South America. It is found in Belize, Guatemala, Honduras, Costa Rica, Panama, Peru, 
Argentina, Bolivia, Paraguay, Colombia, Venezuela, throughout the Amazonian forest below 
heights of 2000 meters, and in hot forests of the pacific coast of Colombia and Central 
America. Zymodeme analyses showed great heterogeneity of L. brasiliensis. It possibly went 
through changes in reservoirs and vectors as a natural result of adaptation to all the different 
settings  (Oliveira-Neto et al., 1988). Incidental infections have been found in many genera 
like dogs, equines in the suburban areas (Aguilar et al., 1987), while the natural forest 
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reservoirs have not been yet identified. Some of the sandfly vector species are Ps. welcomei, 
Lu. whitmani and Lu. intermedia, all of them are anthropophilic (Aguilar et al., 1987). 
 
L. panamensis is responsible for leishmaniasis in Costa Rica, Honduras, Nicaragua, Panama, 
Colombia and the pacific coast of Ecuador. Its natural host is the sloth Cleopus hoffmanni 
(Herrer et al., 1980) and accidental infections were reported in wild animal species and in 
dogs. Infection rates in humans are also high in the areas mentioned above (Sanchez et al., 
1992). 
 
L. guyanensis is restricted to the Amazonian forests of Brazil, Colombia, French Guyana, 
Guyana and Surinam. Its natural hosts are the arboreal sloth Choleopus didactylus, the 
anteater Tamandra tetradactyla and Choleopus marsupialis. The main vectors are Lu. 
umbratilis and Lu. Anduzei (Dedet et al., 1989).  
 
L. peruviana is responsible for CL in the high valleys of the Peruvian Andes and the 
Argentinean highlands. By isoenzyme analysis it can not be distinguished from L. 
brasiliensis. Dog is considered the urban reservoir but there is no information for a wild one. 
Lu. peruenis and Lu. verrucarum are the vectors (Llanos-Cuentas et al., 1999). 
 
L. brasiliensis, L. peruviana, L. panamensis and L. guyanensi, are the main causative agents 
of mucocutaneous leishmaniasis in central and South America. 
 
L. mexicana is prevalent in the Yucatan peninsula of Mexico, through Guatemala, Honduras, 
Panama and Colombia. It causes CL and DCL. Various forest rodents are the reservoir. 
Almost 90 % of Yucatan males that work in the forests are leishmanin positive (Andrade-
Narvaez et al., 1990). 
 
L. amazonensis infections are reported from the Amazon forests of Brazil, Bolivia, Colombia, 
Ecuador, Peru, French Guyana and Venezuela. Forest rodents carry skin infections and the 
vector Lu. flavisculleta is widespread but not anthropophilic. Thus human infections in the 
area are relatively rare but there is a high rate of DCL cases and some VL cases (Barral et al., 
1991). 
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There may be many more species as it has been mentioned before but the information is still 
scarce. Leishmanial parasites closely related to L. mexicana have been reported from Texas 
and the Dominican Republic (Schnur et al., 1983). Two unnamed species have been found in 
Namibia (Grove, 1989), Angola, Zaire and Tanzania, one in man and one in the rock hyrax 
Procavia capeses, but fundamental understanding of the life cycle and epidemiology is still 
needed. A rarer species of Leishmania, Leishmania donovani archibaldi, has infrequently 
been reported to cause leishmaniasis in the Horn of Africa (Lainson et al., 1987). 
The geographical distributions are greatly overlapping making it very difficult many times to 
distinguish the one from the other. Worldwide, the disease is common and grossly unreported. 
Zoonotic and human infections are often associated with environmental changes and the 
transmission cycles adapt (Shaw et al., 1987; Lainson, 1983) to new conditions. 
 
 
2.2.2 Pathogenesis and clinical features of leishmaniasis 
 
Leishmaniasis is a variable disease with a variety of syndromes that are manifested alone or in 
combinations (Garnham, 1987).  
 
The incubation period ranges from a few days to several months. The sandflies are biting 
humans and animals in the uncovered and hairless areas of the body. At the inoculation site an 
erythematous nodule appears. The nodule grows to an ulcer with a raised edge. This sore 
remains often in that stage without further development and when it heals it leaves scar tissue. 
Scars can even disable if they are on the face or over a joint. 
 
After inoculation of the parasite through the sandfly bite, Leishmania promastigotes are 
phagocytosed in the skin by activated macrophages. Patients with acute leishmaniasis fail to 
produce T helper cell 1 (Th1) cytokines and the parasite interferes with the killing mechanism 
of the macrophages (Bogdan  et al., 1990; Russo et al., 1992). The parasites transform into 
amastigotes and start to divide. Amastigotes have an affinity for macrophages and endothelial 
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cells of arterioles and capillaries, leading to tissue lysis and necrolysis. Then one of the 
following events finds place: 
• The immune system kills the parasites and the person becomes immune to reinfection by 
that species. 
• A local infection develops until either the immune system of the host eradicates it or is 
defeated by it permitting dissemination. 
• The infection disseminates to the viscera (L. infantum, L. chagasi), oronasal mucosa (L. 
brasiliensis) or skin (L. aethiopica, L. mexicana). 
Parasites multiply in the cells of the mononuclear phagocyte system like blood monocytes, 
macrophages, histiocytes, epithelioid cells, Kupffer cells of the liver, reticuloendothelial cells 
in spleen and lymphoid tissue. 
 
Clinical pictures (based on Bowman, 1995; Cook, 1996 and Garcia et al., 1993) 
2.2.2.1  Cutaneous leishmaniasis (CL) due to L. major has an incubation period of 1 
week to 2 months. Lesions develop to necrotic foci rapidly and they become inflamed and 
exudative wet sores. Lesions do not spread to the mucosa and are often located on the limps 
(Nadim et al., 1968). During epidemics the disease is quite severe, with multiple lesions 
deeply ulcerated, and all ages are affected. 
CL due to L. tropica is slower in evolution and affects more the children. The initial nodule 
may develop a few satellite nodules but in is crusting slowly and heals. 
CL due to L. infantum and L. chagasi is even less aggressive. The lesions are nodular, they 
never ulcerate and last 1-3 years. 
CL due to L. aethiopica causes solitary lesions centrally on the face. Many times a spreading 
nodule, tumour or plaque develop and if the lesion reaches the border of the nose or mouth, 
the infection may spread along the mucocutaneous margins but does not spread into the 
oronasal cavities. Sores heal slowly over 2-5 years. 
CL due to L. brasiliensis causes single, deep, fast developing ulcers. 80 % of the sores heal 
within one year. 
CL due to L. guyanensis is often presented with multiple lesions and up to half of the cases 
have lymphatic spread and even oedema. 
CL due to L. panamensis is also associated with lymphatic and lymph node involvement and 
sores persist for years. 
CL due to L. mexicana is often known by the "chiclero ulcer", which is CL eroding the 
cartilage of the pinna of the ear. 
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CL due to L. amazonensis produces solitary lesions but not much is known about their 
evolvement. 
 
2.2.2.2  Diffuse cutaneous leishmaniasis (DCL) occurs in about 1 per 10 000 
infections with L. aethiopica (Bryceson, 1970). The primary lesion does not ulcerate but the 
infection spreads slowly through the bloodstream and relocates. The clinical picture often 
resembles to lepromatous leprosy and cause grotesque deformity. Spontaneous healing is rare 
in this case. 
 
2.2.2.3  Leishmaniasis recidivans (LR) is a condition that can result in infection with 
L.tropica. It has the clinical picture of Lupus vulgaris and represents persistence of the 
infection in the face of a vigorous immune response (Pettit, 1962). 
 
2.2.2.4  Visceral leishmaniasis (VL) is due to L.donovani in India and West Africa, 
L.infantum in the Mediterranean basin and L.chagasi in Central and South America. 
Incubation period ranges from 3 weeks over 2 years (Jopling, 1955). It is also known as kala-
azar, which is the most severe form of the disease which if left untreated, has a mortality rate 
of 100 %. It is characterized by irregular bouts of fever, substantial weight loss, swelling of 
the spleen and liver, and anaemia. Globulins are over-produced in the beginning but immune 
complex-mediated disease is rare in humans (Pearson et al., 1983), while it is quite common 
in dogs (Koutinas et al., 1995). In Sudan and in the Mediterranean area the disease may be 
present as afebrile lymphadenopathy. Abdominal pain is due to the enlarged spleen. Epistaxis 
is common but usually no other form of haemorrhage.  The differential diagnosis stands 
amongst leishmaniasis and malaria, brucellosis, bacterial endocarditis, typhoid, miliary 
tuberculosis and haemopoietic malignancy. Very often patients in an endemic area may not 
seek attention for up to a year (Cole, 1944; Maru, 1979). In the Mediterranean VL skin lesions 
in human are uncommon (Sciliro et al., 1978). Still the clinical picture in the dogs (Kontos et 
al., 1993, Koutinas et al., 1999) is involving variable cutaneous lesion (exfoliate dermatitis, 
skin ulcerations) ocular lesions (conjunctivitis, keratoconjuctivitis sicca, blepharitis, uveitis), 
poor body condition (Koutinas et al., 1992), chronic renal failure, peripheral 
lymphadenopathy or lymph node hypoplasia and masticatory muscle atrophy (Vamvakidis et 
al., 1999),  
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2.2.2.5  Post-kala-azar dermal leishmaniasis (PKDL) is a sequel to the infection with 
L.donovani. Most patients have a history of previous treatment for VL, self-healing illness 
resembling VL, or no history. PKDL in India resembles lepromatous leprosy with verrucous, 
papilomatous, xanthomathous and gigantic nodular forms (Morgan, 1962), while in East 
Africa it resembles more to sarcoidosis and tuberculosis with papular rash over face or well-
defined rounded papules (Rashid et al., 1986). 
 
2.2.2.6  American mucosal leishmaniasis (Llanos-Cuentas et al., 1984; Walton, 1973; 
Marsden, 1986). Almost 40% of the patients with cutaneous ulcers are infected by L. 
brasiliensis and a smaller portion with L. guyanensis and L. panamensis. The initial lesion is a 
nodule, usually on the anterior septum or inferior turbinate and the initial symptom is nasal 
obstruction or epistaxis. The infection spreads from the mucosa to the mucocutaneous 
junctions of the lips and nose and sometimes on to the surrounding facial skin and/or 
conjunctiva. Complications that often show up are nasal, pharyngeal and laryngeal obstruction 
from exuberant growth or fibrotic stenosis. Death may also ensure from secondary sepsis, 
pneumonia or starvation while spontaneous healing is unusual. 
 
 
 
2.3 Leishmaniasis in immunosuppressed patients 
In 1986 a new dimension of VL leishmaniasis was recognised when the first reports of VL as 
a complication to the HIV infection arrived (Altes et al., 1991; Alvar et al., 1992). Some of 
those cases are considered to be reactivation of latent infections and some new infections 
where normal defence mechanisms are impaired (AIDS), absent (congenital diseases), or 
bypassed (penetration of the skin barrier), and finally the cellular immunity is failing to 
respond. Most reports are coming from South Europe where both VL due to L. infantum and 
HIV are endemic, and some from Brazil. In Spain it is estimated that 50 % of adults with VL 
are HIV positive, and that 3 % of HIV-infected individuals will acquire VL (Pintado et al., 
2001). The disease responds slowly to treatment and relapse is very common. AIDS and VL 
are locked in a vicious circle, since the one reinforces the other. VL quickly accelerates the 
onset of AIDS (with opportunistic diseases as tuberculosis or pneumonia) and shortens the life 
expectancy of HIV-infected people. The coinfected people often exhibit unusual clinical 
symptoms, which can make diagnosis difficult (WHO, 2000).  
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AIDS increases the risk of VL by 100-1000 times in endemic areas. Both the HIV virus and 
Leishmania parasites, destroy the same cells and increase the disease severity and 
consequences (WHO, 2000). The evolution of Leishmania/HIV co-infection is being closely 
monitored by extending the geographic coverage of the surveillance network and by 
improving case reporting. WHO encourages active medical surveillance of HIV patients and 
intravenous drug users, main population at risk. Also case notification is compulsory in only 
40 of the 88 endemic countries. Thus WHO strongly suggests the remaining 48 endemic 
countries to follow suit. A graphic example is given in the WHO map that follows (Figure 1). 
 
 
 
 
Figure 1: Countries reporting leishmaniasis/HIV co-infections (taken from the
WHO at http://www.who.int/emc/diseases/leish/leisgeo1.html) 
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2.4 Treatment  
The intracellular site of development of the parasite in leishmaniasis patients makes particular 
pharmacokinetic demands upon drugs. 
2.4.1 Pentavalent antimonials (sodium stibogluconate, meglumine antimoniate) remain the 
drugs of choice for reasons of cost, availability and efficacy together. However, cases of 
antimony resistance were reported from epidemics in India and Sudan (Thakur et al., 1988; 
Seaman et al., 1993), and in the case of HIV coinfected patients, relapse is the common 
follow-up. Also dose schemes in excess of 20 mg Sb/kg BW (Body Weight) should be 
monitored daily because of the side effects. 
2.4.2 Aminosidine (paromomycin) is an aminoglycoside antibiotic, non-toxic in conventional 
doses in patients with normal renal function but because of its aminoglycoside properties, has 
all the potential for renal and ototoxicity. Given with antimonials it has a unique synergistic 
effect than either drug alone (Seaman et al. , 1993; Scott et al., 1992; Chunge et al.,1990). 
Aminosidine ointment (15 % with 15 % urea in white shoft parafin) cures 80 % of the Old 
World sores if applied for up to 12 weeks (Bryceson et al., 1994). 
2.4.3 Pentamidine has been a traditional drug for leishmaniasis as well, administered for 15 
days on a dose 2-4mg/Kg . It is also an effective drug but its potential side effects overlap its 
effectiveness, including hypoglycaemia followed by diabetes mellitus, hypotention (if 
administered rapidly), nausea, vomiting, abdominal pain and headache (Pearson et al., 1996). 
2.4.4 Amphotericin B has proved to be 400 times more potent than antimonials against 
Leishmania because it binds to ergosterol, the major cell membrane sterol of amastigotes 
(Davidson et al., 1993), causing an impairment of barrier function that results in the loss of 
protons and cations from the cell (Warnock, 1991). Nevertheless, despite its effective 
properties (Davidson et al., 1993) the conventional Amphotericin B desoxycholate is little 
employed because of the side reactions of fever and phlebitis during infusion, anaemia, kidney 
dysfunction, and hypocalaemia (Utz, 1964). 
2.4.5 Liposomal Amphotericin B . The formulation of AmBisome (Vestar, San Dimas, CA, 
USA) has been licensed as antileishmanial drug. The size of the vesicles in which 
Amphotericin B is encapsulated is 80 nm. Once intravenously injected liposomes escape to a 
very small extent from the intravascular space. Vesicles of an average size 100 nm, can pass 
through the fenestrae in the liver to reach the hepatic parenchyma cells, the fixed macrophages 
and the monocytes, by which they are endocytosed (Gregoriadis, 1991). After that, they end 
up in the lysosomal apparatus of the cells, the vesicles are disrupted by phospholipases and 
freed drug can diffuse through the lysosomal membranes to reach other cell compartments (the 
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parasitophorus vacuole and the parasite). All the above, very well explain the high efficacy of 
the drug in treatment of visceral leishmaniasis (Croft et al., 1991; Berman et al., 1986), the 
high value of the drug half life remaining detectable for long time after treatment (Gangneux  
et al., 1996), the administration of lower doses in short courses (Castagnola et al., 1996) and 
its one-tenth less toxicity comparing to conventional Amphotericin B (Proffitt, 1991). 
 
The economical condition of the endemic areas is very poor, and for reason of meeting 
effectivity with low cost of treatment, pentavalent antimonials are the drugs of choice in those 
areas. For the same reason they are the ones suggested from the WHO. 
 
In the cases of canine leishmaniasis long term therapy courses are recommented with 
Allopurinol 20 mg/kg/day per os for months to years, which manifests a clinical healing but 
doesn't eliminate the parasite. Combinations of Allopurinol 100 mg/kg/day and 
megluminantimonate 30 mg/kg/day until healing of the clinical symptoms and then long-term 
courses of 1 weekly therapy per month with 20mg/kg Allopurinol. Antimonials of course are 
in use, Megluminantimonate (1st and 2nd day 100 mg/kg, 3-10 days 200-300 mg/kg and 2x in 
time distance of 14 days s.c. in the chest area or very slow i.v.), Natrium-Stibogluconat (10-20 
mg/kg dayly for 2x10 days with a 10 days interval with a lot of liquids i.v.) and Diamidine 
Pentamidin (2-4 mg/kg util 5x with 3-3 days time distance between them i.m. or 2 mg/kg 
dayly for 14 days given in 500 ml liquid i.v. slowly). All three give a clinical healing that 
rarely lasts. Dogs with nephritis following antimonial treatment are a phenomenon often 
observed. Also treatment with Paromomycin, a liposomal formulation of Amphotericin B (0.5-
0.8 mg/kg 2x per week i.v. until an accumulative dosis of 8-16 mg/kg is reached), gave mostly 
a temporary result (Rommel et al., 2000). Along with the systemic treatment the skin ulcers 
should be at the same time treated with the appropriate antibacterials. The development of a 
vaccine is in embryonic stages and tourists should seriously consider whether they should let 
their dogs escort them while travelling in the Medditeranean. In such cases dogs can be treated 
with Permethrin (10 mg Permethrin pro kg) washings or baths every 1-2 weeks during the 
exposition time, and/or carry Permethrin collars. 
 
Vector control methods are hardly established in the case of the sandfly vectors. Details in 
their life cycle are often not known. The breeding places in the various areas are still not 
clearly defined in detail. Conventionaly impregnated bed nets are inefficient because of the 
small size of the sandflies. Nevertheless there is evidence that deltamethrin-impregnated 
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collars protect domestic dogs from sandfly bites. Dogs wearing the collars were bitten by 
approximately 80 % fewer sandflies than before collars were fitted (Halbing et al., 2000). 
 
 
2.5 Diagnosis of leishmaniasis 
 
2.5.1. Parasitological diagnosis 
In VL and CL, parasites may be isolated from 80 % of the sores during approximately the first 
half of their natural course (Cuba et al., 1984). Tissue juice, not blood is scraped with a scalpel 
blade from a nodule. The nodule is previously grasped firmly between finger and thumb to 
exclude blood and an incision of a few mm long is made into the dermis. The material 
obtained can be used to prepare a smear that will be stained with Giemsa, Wright's or 
Leishman's stain, or inoculate culture media for the isolation and the culture of the parasite. 
Biopsy smears may be used for culture, inoculation into hamsters, impression smears or 
immunohistology in tissue sections (Sells et al., 1981). Lesions smears and culture are best in 
cases with cutaneous lesions and biopsy and hamster innoculation when mucosal lessions are 
predominant.  
 
In VL splenic aspiration is the most sensitive method (Chulay et al., 1983). The obtained 
material is used to inoculate culture tubes and make smears. Same procedure is followed for 
patients with AIDS (del Mar Sanz et al., 1991). Bone marrow and lymph node aspirations 
have proved to be very useful as well. Lymph node aspirations are especially useful in routine 
field diagnosis in both human and dogs. 
 
 
2.5.2 Serological diagnosis of leishmaniasis 
 
2.5.2.1  Leishmanin (Montenegro) test: The test measures delayed type 
hypersensitivity to Leishmania antigens. Leishmanin is a suspension of washed promastigotes 
in a solution of 0.5 % phenol in saline. The antigen must be standardised against cases and 
controlled in the endemic area (Leeuwenburg et al., 1983). 0.1 ml solution is inoculated into 
the volar surface of the forearm. The area is measured 48-72 h later. The test comes out 
positive in over 90 % of the CL and ML cases, less frequent in L. aethiopica infections and in 
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ML with multiple sites of disease (Cuba et al., 1984). In active VL it is negative but within 
several months to a year after recovery, individuals elicit a positive response. Overall it is a 
good test for epidemiological surveys of a population to identify groups at risk of infection 
from CL (Weigle et al., 1991). 
 
2.5.2.2  Indirect Immunofluorescent Antibody Test (IFAT): The procedure of the 
IFAT test uses as antigen whole Leishmania promastigotes. Dried antigen slides are stored at -
70°C until use. A two-fold serial dilution of the test serum in phosphate buffered saline (PBS) 
is placed on 12 spots slides. The dilution may vary from 1:1 up to 1:1040 or further. 
Fluorescein-conjugated goat anti-human IgG at an optimal dilution is added to each spot. The 
slides are considered to be positive when more than 50 % of the parasites show complete 
peripheral flourescence (Pappas et al., 1985). In different studies a reasonable sensitivity and 
specificity ranging from 80 % to almost 100 % was reported but cross reactions were observed 
with sera obtained from malaria, American trypanosomiasis, schistosomiasis, leprosy and 
syphilis patients (Latif et al., 1979). Researchers tried to overcome some of this problem by 
first absorbing the sera with a Trypanosoma cruzi lysate (Camargo et al., 1969).  
 
L. brasiliensis promastigotes were unsuccessful as antigen for IFAT, while amastigotes gave 
good results (Walton et al., 1972). 
 
IFAT has proven to be very suitable for the detection of reservoir hosts of leishmaniasis like 
dogs, foxes and rodents in the Mediterranean area (Manciati et al., 1986; Sideris et al., 1999), 
in Brasil (Courtenay et al., 1994) and in Iran (Zovein et al., 1984). 
 
In western Turkey 490 dogs, were examined using either IFAT or direct agglutination test 
DAT. Anti-Leishmania antibodies were found by at least one test in 5.3% (26/490) of the 
dogs. Infections were confirmed by parasitological examination of or polymerase chain 
reaction (PCR) on lymph node aspirates in 65% and 76.4% of the seropositive dogs tested, 
respectively. The confirmation rate was 85% by combining the results of PCR and 
microscopy (Ozbel et al., 2000). 
 
2.5.2.3  Enzyme-linked immunosorbent assay (ELISA): In this method the antigen is 
being absorbed on the surface of a well or a microtiter plate, then the patients serum is added 
and the antibodies bind to the antigen forming the antibody-antigen complex. Non reacting 
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molecules are washed away and an enzyme-linked anti-IgG is added, followed by the 
substrate. The enzyme is detected by the amount of colour produced and is relevant to the 
amount of antibodies present in the patient's serum. 
 
Engvall and Perlmann (1972) and Schnur and Zuckerman (1977) developed the first ELISAs 
for antibody detection. Variations evolved from that. 
 
A modified DOT-ELISA was developed (Pappas et al., 1984; 1985) where formalin fixed L. 
donovani promastigotes were fixed on filter discs, placed in a microtiter plate. The sensitivity 
of this method was 98 %, however there was high cross reactivity with sera from patients 
suffering from African trypanosomiasis, Chagas' disease and lupus erythematosus. Adhya et 
al. (1995) found anti-Leishmania antibodies in the blood of 23 out of 39 early VL patients, 
using immobilised crude antigen of L. donovani, that captured antibody in serum 1:500 (Jaffe 
et al., 1987). 
 
Today the standard micro-ELISA using intact promastogotes obtained from in vitro culture as 
antigen, is in practice in cross-sectional and longitudinal studies of leishmaniasis giving good 
results but still cross reacting in the co-endemic areas with sera from patients with African 
trypanosomiasis (El Amin et al., 1986).  
 
To eliminate cross-reactions different sets of chemically defined peptides are used, which are 
conjugated to a protein carrier such as bovine serum albumin (BSA) (Hommel et al., 1997). 
Application of different sets of synthetic peptides, such as a set of five peptides derived from 
the amino acid sequence of a gp63-like protein (Fargeas et al., 1996), lead to lower sensitivity 
(71 %) but increased specificity (93 %) compared to the crude antigen ELISA (80 % and 79 
%, respectively). Other sets of peptides used in other studies were the fucose-mannose ligand 
(FML) (Palatnik-de-Sousa et al., 1995) and a glycoprotein present on the promastigotes and 
amastigotes of L. donovani. Also the C-terminal region of the 70 kilodalton (kD) heat shock 
protein of L. brasiliensis (Amorim et al., 1996), a 28 amino acid sequence derived from the 
repetitive element of gene B protein (GBP) of L.major (Jensen et al., 1996). The rK39, a 
recombinant product consisting of the 39 amino acid repeat which is part of a 230-kD protein 
predominant in the L. chagasi amastigotes (Burns et al., 1993) was tryed as well. They all 
gave variable sensitivity and specificity numbers dependent on the Leishmania species 
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infecting the patients, but no cross reactivity and none gave a catholic sensitivity and 
specificity result for all different kinds of leishmaniasis. 
A purified 200-kDa antigenic fraction from L. donovani axenic amastigotes was diagnostically 
evaluated by ELISA for the detection of antibody response in VL, PKDL and control patients. 
It seemed to have a potential prognostic significance and may be able to differentiate between 
VL and PKDL (Kaul et al., 2000).  
 
The main problem with ELISA is, that like other serological tests it can not distinguish 
between current, clinical and past infection (Hommel et al., 1997). 
 
2.5.2.4  Western Blotting: For western blotting, proteins are originally separated by 
sodium-dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred 
to a nitro-cellulose or nylon membrane. If there are antibodies present in the patient sample, 
they react with the components of the membrane and the antibody-antigen complex can be 
detected as in ELISA.  
Jaffe et al., (1984), using western blot and/or radioimmunoprecipitation analyses, recovered 
five distinct groups of indicabble Leishmania antigens comprising of 20 different molecules, 
and ranging from 18 to 84 kDa. All of them were recognised by the monoclonal antibodies D-
2, D-10, and D-13 and from  antibodies present in the sera of VL patients. Evans et al., (1989), 
found that the most frequent bands are at 116 kDa, 70 kDa, and 26 kDa; less frequent at 93 
kDa, 74 kDa, 62 kDa, 46 kDa and 32 kDa. The patterns were very distinct for VL and could be 
used to differentiate patients with VL from those with Chagas' disease or CL. 
De Colmenares et al. (1995) suggested a non-invasive method for VL diagnosis. He detected 
fractions of 72-75 kDa in the urine of 14 out of 15 VL patients and a fraction of 123 kDa in the 
urine of 10 of the 15 patients. 
Mary et al. (1992) studied the sera of 37 VL patients, 11 of them HIV/VL patients. He found 
that antigens of 14 kDa were detectable in 92 % of the VL patients and of 16 kDa in 95 % of 
the sera. Same resulted from the HIV/VL patients; the 14 kDa band was not present in some 
samples while the 16 kDa one was constantly there. 
 
Using immunoblot analysis in India in 35 kala-azar patients and 67 controls, the antibody 
response to five antigens (40kDa, 55 kDa, 65 kDa, 70 kDa and 82 kDa) of L. donovani was 
examined. The majority (83%) of kala-azar cases recognised at least four of these five parasite 
antigens (Salotra et al., 1999). 
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 2.5.2.5  Direct Agglutination test (DAT): In this test the antigen preparation consists 
of whole organisms and a serological response (mainly IgG) recognises surface-born antigens 
of the parasite. DAT is a relatively fast and simple technique, with high sensitivity and 
specificity (Hommel et al., 1997; Meredith et al., 1995), thus one of the most widely used 
immunological tests that has been applied in diagnostic and epidemiological studies.  
The main disadvantages of it are cross-reactivity (Hommel et al., 1997), the persistence of the 
antibodies after apparent cure (Hommel et al. 1997, Zijlstra et al., 1991), and the thermal 
instability of the aqueous antigen (Zijlstra et al., 1997). 
An improved DAT based on stable, freeze-dried antigen, has been developed for use on canine 
serum samples (Dog-DAT) which showed a sensitivity of 100 % and specificity of 98.8 % 
(Oskam et al., 1996). DAT showed its value in large-scale sero-epidemiological surveys in 
eastern Sudan (Zijlstra et al., 1991), the Mymensingh district of Bangladesh (Chowdhury et 
al., 1993) and in the Himalayas (Rab et al., 1995). 
 
DAT was used in 2 villages in Sudan, screening domestic animals (donkeys, cows, sheep, 
goats, camels and dogs in a search for the L. donovani transmission cycle. DAT detected 
reaction rates above the cut-off titres in donkeys (68.7%), cows (21.4%) and goats (8.5%), 
and in wild rats (5.5%) while ELISA showed reaction rates above the cut-off optical density 
in cows (47.6%), goats (13.6%), and in rats (4.1%) (Mukhtar et al., 2000) 
 
 
 
2.5.3 Molecular diagnosis of leishmaniasis 
 
2.5.3.1  Polymerase chain reaction (PCR): PCR is the amplification of a known 
specific nucleic acid sequence, using oligonucleotide primers (around 20-mers), which 
specifically bind to the DNA flanking the region of interest. The amplification is achieved by 
using a heat-stable DNA polymerase isolated from Thermus aquaticus (Saiki et al., 1988). The 
target DNA is denatured at 94°C and the double strands (ds) become single strands (ss). Then 
the primers are allowed to anneal at a temperature specific for each set (somewhere between 
50-65°C). So after each amplification cycle, each double stranded DNA molecule gives rise to 
two ds copies of target DNA. PCR products are visualised after gel electrophoresis and 
Southern blotting. 
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 A variety of clinical materials have been used for detection of Leishmania, like bone marrow, 
lymph node aspirates and peripheral blood, skin scrapings or sand flies. A variety of target 
sequences has been used as well, but maximum sensitivity has been achieved by using multi-
copy sequences like ribosomal RNA genes, kinetoplast DNA, mini-exon-derived RNA genes 
and genomic repeats. The specificity of the PCR can be adapted to specific needs by targeting 
conserved or variable regions (Weiss, 1995). 
 
In bone marrow taken from parasitologically confirmed VL patients, parasite DNA was 
amplified by PCR in all samples by Andresen et al. (1997), all by Mathis et al. (1995) and all 
samples by Osman et al. (1997). In a comparative study, Piarroux et al. (1994) showed that the 
sensitivity of PCR was 82 %, of microscopy 55 % and of culture 55 %; using bone marrow 
aspirates through all diagnostic approaches. 
 
In human lymph node aspirates Leishmania DNA was detected in all 6 samples by Andresen  
et al. (1996) and in all 33 of 38 sample by Osman et al. (1997). In peripheral blood preserved 
in filter papers, from parasitologically confirmed VL patients, sensitivity was 63 % (Meredith 
et al. 1993), and 70 % (Osman et al. 1997). Andresen et al. (1996) used venous blood and the 
sensitivity was 92.5 %. Adhya et al., (1995) found that PCR was able to detect Leishmania 
DNA in 77 % of Indian VL patients at an early stage of the disease. Mathis et al (1995) 
demonstrated Leishmania DNA in leukocytes from the Ficoll-Plaque, in 64 % of blood 
samples from HIV/Leishmania co-infected patients, both in PCR and in culture. 
 
In 60 % of skin biopsies (Mathis et al., 1995), from patients with CL, PCR detected parasite 
DNA, while in a comparative study by Andresen et al., (1996), 86 % of the samples taken 
from CL patients were positive whereas microscopy detected only 55 % of the samples. In the 
cases of PKDL, Osman et al. (1998), using slit skit, demonstrated a 83 % sensitivity by PCR 
and only a 30 % sensitivity by microscopy). 
 
In the case of epidemiological studies PCR has been used in a limited extent but with very 
impressive results though. El-Hassan et al. (1993), reported the presence of Leishmania in 
Arvicanthis niloticus, a vector of L. donovani in eastern Sudan, while Mathis et al. (1995), 
using canine samples, had a 100 % sensitivity in lymph node aspirates but 38.5 % in blood 
samples. Carreira et al., (1995) in Central America showed that PCR provided rapid diagnosis 
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with a sensitivity of 60 % and with a degree of concordance of 87 % to the different molecular 
techniques used. 
 
2.5.3.2  Polymerase chain reaction solution hybridisation enzyme-linked assay 
(PCR-SHELA): In the case of L. donovani complex, a 60 bp repetitive degenerate sequence 
(Lmet2) was found (Howard  et al., 1991a). Qiao et al., (1995) developed an assay which 
targets the this sequence combined with post-PCR hybridisation and colorimetric detection in 
microtiter plates coated with avidin. One of the primers was labelled with digoxigenin and a 
biotinylated probe was used for hybridisation that was binding to avidin and to the labelled 
primer. Substrate addition produced a colorimetric reaction and absorbency was measured at 
405 nm after 1 h using an ELISA reader. The sensitivity of this PCR-SHELA was found to be 
very high, as few as 5 parasites could be reliably detected, and the assay appeared to be semi-
quantitive. A main problem with this technique was that when PCR products were checked on 
an agarose gel, the resulting bands were very smeary, most possibly because a tandemly 
repetitive sequence was used (Kokozidou, 1996). 
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2.6 Species and strain identification 
 
2.6.1  Enzymatic identification (isoenzyme analysis): Isoenzymes are variant 
enzymes with identical functions. Each of them in sample may appear as one of several 
alternative bands after electrophoretical separation. A pattern is defined as a unique 
arrangement of one or more bands displayed by one or more enzymes. The series of bands 
(one per enzyme), produced by a given isolate is its enzyme profile. Groups of isolates having 
the same isoenzyme profile are called zymodemes (Rioux et al., 1990). 
 
Following the recommendations of an expert committee, each zymodeme is labelled with 
either London School of Hygiene and Tropical Medicine or University of Montpellier 
designation, e.g. LON-1 or MON-1 (Piarroux et al., 1994). 
 
Isoenzyme analysis is time consuming and tedious (Andresen et al., 1996), requires prior 
cultivation of the parasites and is performed in specialised laboratories only today. The main 
drawback of isoenzyme analysis is that only those mutations in proteins are detected that lead 
to an altered charge of the molecule. Furthermore, selection may act on the enzymes used 
(Taylor et al., 1999) 
 
2.6.2  Southern blotting using DNA probes: Van Eys et al., (1989) developed the 
method first, using two recombinant probes pDK10 and pDK20 derived from nuclear DNA. 
The pDK10 probe could differentiate the Old World CL-causing species from the L.donovani 
complex and the pDK20 probe was able to distinguish between all Old World Leishmania 
species (Van Eys et al., 1991). 
 
Most researchers that moved that direction targeted mainly kinetoplast DNA (kDNA), because 
it molecules exist in 10 000 copies and have variable regions that differ amongst minicircle 
classes in the same network (Simpson, 1987; Barker, 1989). Smith et al., (1989) developed 
kDNA minicircle sequence probes for L. major, but they cross reacted with L. infantum. 
Gramiccia et al., (1992) developed a probe from a minicircle fragment from a dermatotropic L. 
infantum strain which showed only week hybridisation to L. donovani and L. chagasi but 
equally detected dermatotropic and viscerotropic strains. An L. aethiopica specific sequence 
was reported by Laskay et al., (1991).  
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Lee et al., (1995) found an A+T rich repeat DNA sequence from the divergent region of the 
maxicircle DNA of L. amazonensis, which was conserved only to these species which were 
infective to man and not to the non-infective ones. Howard et al., (1991) recovered the Lmet2 
sequence, a 60 bp repetitive degenerate sequence from L. donovani, that specifically hybridise 
only to the L. donovani complex. 
 
2.6.3  Use of species specific primers in PCR: The PCR can be adapted to specific 
needs by targeting conserved or variable regions and thus it is possible to characterise the 
parasite present in the specimen to the genus complex or species level. 
 
Primers were designed to amplify a L. donovani minicircle sequence. Cross-reactions were 
present with other Leishmania spp. (Smyth et al., 1992). Because of the great variability 
within the kDNA the use of probes is limited to the geographical region from which the isolate 
comes from (Meredith et al., 1993). Bhattacharyya et al., (1993), were able to detect CL 
species using primers derived from the conserved and variable regions of a kDNA minicircles.  
 
Ramos et al., (1996) could distinguish the L. brasiliensis, L. donovani and L. mexicana 
complexes, the L. major and L. aethiopica species, and couldn't distinguish between L. tropica 
and L. aethiopica species. They used primer pairs generating mini-exon intergenic regions and 
repeats. 
 
The internal transcribed spacer (ITS), located between the small subunit rRNA and the large 
subunit rRNA genes and include the 5.8S rRNA gene region, was amplified by Schönian et 
al., (2000). Consistent size variations were observed among various Leishmania species 
(Schönian, personal communication, unpublished results).  
 
2.6.4    Restriction fragment length polymorphism (RFLP) of an amplified region: 
Restriction enzyme digestion of PCR products allowed further differentiation. Van Eys et al., 
(1992) could distinguish L. donovani and L. brasiliensis from the other species by their 
characteristic restriction pattern after digesting the PCR product (small subunit ribosomal 
RNA genes) with restriction enzymes such as Rsal and Hhal. Cupolillo et al., (1995), digested 
the ITS region with 10 different restriction enzymes, demonstrating a variety of intra- and 
inter- specific variations, in a number of New World Leishmania isolates. Espinoza et al., 
(1995), amplified the Gp63 region in 58 L. peruviana isolates and exposed the amplicons 
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EcoRI and SalI, demonstrating 19 and 16 distinct RFLP patterns respectively. Also digestion 
of the ITS region was used by Schönian G et al., (2000), in accordance to a PCR with single 
primers fingerprinting technique, to reveal genetic heterogeneity among 10 L. aethiopica 
isolates examined. In principle this method can be used for direct detection of Leishmania in 
clinical samples (without cultivation, for the identification of Old World and New World 
species of Leishmania (RFLP) but also for strain typing (RFLP and/or SSCP). 
 
2.6.5  AP-PCR (Arbitrarily Primed PCR) and RAPDs (random amplified 
polymorphic DNAs) as fingerprinting methods. 
Three PCR- based methods for DNA fingerprinting were developed in the early 1990s. 
Arbitrarily primed PCR (AP-PCR) by Welsh and McClelland (1990), random amplified 
polymorphic DNA (RAPD) assay by Williams et al., (1990) and DNA amplification 
fingerprinting (DAF) by Caetano-Anollés et al., (1991). The common strategy that underlies 
them all is that they are all based on the use of arbitrary primers that perform the PCR 
amplification of random genomic DNA fragments. Each primer or combination of them 
generates a characteristic pattern of amplification products, which is visualised by either 
radionuclide incorporation, ethidium bromide or silver staining. Polymorphisms between 
individuals or strains are detected as differences between the patterns of DNA fragments from 
different DNAs using a given primer or set of primers. This strategy provides a number of 
advantages over the classic DNA fingerprinting through RFLP because it permits easy and 
rapid generation of polymorphic markers since it uses very small amounts of DNA and does 
not require any knowledge of target DNA sequence. 
 
The above three methods basically differ from one another in the length of primers used, 
amplification conditions, separation, visualisation of amplified DNA fragments and the 
fingerprinting patterns produced. The latter are varying from quite simple (RAPD) to highly 
complex (DAF). 
 
RAPD-PCR amplifies genomic DNA using short primers (9-10 bases) of amplicons separation 
takes place on agarose gels and detection is performed after ethidium bromide staining. It is an 
easier, faster and less expensive method compared with AP-PCR and DAF (agarose gels vs. 
polyacrylamide gels and ethidium bromide staining vs. radionuclide incorporation or silver 
staining). It allows the detection of polymorphisms in closely related organisms and therefore, 
provides a powerful tool for gene mapping, marker-assisted selection in breeding programmes, 
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population and pedigree analysis, phylogenetic studies and individual and strain identification. 
Polymorphisms between individuals or strains result from sequence differences which inhibit 
primer binding or otherwise interfere with amplification and can be simply detected as DNA 
fragments that are amplified from the individual or strain but not from another. Two basic 
criteria must be met when RAPD primers are chosen: a minimum of 40 % G+C content (50-80 
% G+C content is generally used) and the absence of palindromic sequences (Williams et al., 
1993, 1990). 
 
Noyes et al., in 1996, evaluated 28 different RAPD primers. 13 of them yielded patterns of 
taxonomic value when DNA was amplified from 4 different, closely related Leishmania of the 
Viannia group. When kDNA was amplified with RAPD primers it was possible to differentiate 
the cutaneous species and when genomic DNA was used as template different L. donovani 
isolates could be distinguished (Bhattacharyya et al., 1993). Pogue et al., in 1995 used 
successfully arbitrary primed AP-PCR to identify intra- and interspecific Leishmania genetic 
polymorphisms and polymorphic DNA to identify genetic polymorphisms between species 
and isolates. A combination of kDNA-PCR fingerprinting and hybridisation with kDNA 
probes, was found to be useful for both sensitive detection and direct identification of 
Leishmania species (Breniere et al., 1999).  
 
Based upon the same principals a system for the identification and determination of the 
relationships of species and strains within the genus Leishmania was developed using single 
primers in the polymerase chain reaction (Schönian et al., 1996). They demonstrated that 
species-specific PCR profiles were obtained by amplifying the genomic DNA of the Old 
World and New World Leishmania species with different single primers. The PCR profiles 
produced provided a simple way of identification of Leishmania isolates at species level and 
the information from these amplification patterns was used to construct phylogenetic trees and 
to measure the genetic relationship of Leishmania species. The primers that were used were 
annealing to mini- and microsatellite DNA sequences (M13 core sequence), simple repeat 
sequences (GTG5 and GACA4), or derived from an intergenic spacer for tRNA genes (T3B). 
With these primers stringent conditions (high annealing temperatures) could be used for PCR 
which significantly improved the reproducibility of the technique (in contrast to RAPD where 
very low annealing temperatures can be used with the short primers). 
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2.6.6   Single strand conformation polymorphism (SSCP) analysis. 
SSCP analysis represents a comparatively new technique (Orita et al., 1989), which is easily 
implemented and generates useful markers. SSCP analysis is based upon the principle that 
electrophoretic mobility of a single-strand DNA molecule in a non-denaturing gel is dependent 
upon both its size and its shape. A number of stable shapes and conformations are formed 
when secondary base pairing occurs among nucleotides on a single DNA strand (ssDNA). The 
length, location and number of intra-strand base pairs determine secondary and tertiary 
structure of a conformation. Point mutations that affect intra-strand interactions may therefore 
change the shape of a molecule and alter its mobility during electrophoresis. 
 
In principle, the mobility of a denatured single-strand DNA molecule should be sensitive to 
point mutations. Orita et al., (1989) developed SSCP analysis to test this principle and showed 
that intra-strand interactions are highly sensitive to the primary sequence of the molecule. 
Later on, Hayashi (1991), proved in an extensive study that SSCP detects 99% of point 
mutations in DNA molecules 100-300 bp in length and 89% of mutations in molecules of 300-
450 bp in length. 
 
SSCP analysis is methodologically and technically simple. Double-stranded DNA (dsDNA) 
molecules (e.g. PCR product) are denatured to single strands with heat and then plunged into 
ice-water (4°C) to promote the formation of intra-strand complexes while reducing the 
renaturation of the complementary strands. Those products are electrophoresed on 
polyacrylamide gels at 4°C, in cool room, to ensure that intra-strand conformations are not 
disturbed. The gel is then silver stained to detect the mobility of the different DNA 
conformations. Others alternatively have labelled one strand and visualised its conformations 
with autoradiography or enzyme detection. Different researchers used different sizes of gels, 
which all allowed to visualise band shifts (Hiss et al., 1994; Axton et al., 1998). 
 
PCR-SSCP has been successfully used to recognise medically important opportunistic fungi 
(Walsh et al., 1995), to search genetic divergence among species within the parasite Fasciola 
hepatica (Itagaki et al., 1995), to recognise which parasite population of Plasmodium vivax 
causes relapsed infections (Craig et al., 1996), to detect mutations in bilharziasis-associated 
bladder cancer (Tamimi et al., 1996), to search genetic variations of the midkine (MK) gene in 
human sporadic colorectal and gastric cancers (Ahmed et al., 2000) and to analyse mutation 
and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer (Shin et al., 2000). 
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SSCP has been widely used in biomedicine but so far has not been exploited extensively in 
Parasitology. 
 
 
 
2.7     Leishmaniases in the Mediterranean 
 
The Mediterranean basin is what geographically stands between three very different 
continents, very different to their natural and geographical status. There is an interactive 
relationship between them and they also individually receive influences from the further part 
of each continent that stands behind each coast. The Leishmania species that mainly exist 
there are L. infantum, L. major and L. tropica. L. infantum is responsible for the VL, is 
distributed throughout the Mediterranean and infects humans and dogs. L. tropica is restricted 
to Middle East, Tunisia and parts of Southern Greece and is responsible for anthroponotic CL. 
L. major causes rural VL and is widespread throughout North Africa and Middle East. Some 
countries like Tunisia and Israel are suffering from leishmaniases caused by all three species 
(Gradoni et al., 1984). 
 
Leishmaniases are common in the Mediterranean basin, known from ancient years. The first 
reports of kala-azar, called "Ponos" (pain), are coming from the island of Spetses, Greece 
(Karamitsas, 1879; Yiannacopoulos, 1879). In Greece there are two forms of the disease: 
visceral (VL) and cutaneous (CL) leishmaniasis. VL is present in all Greece, continental and 
insular, and is caused by Leishmania infantum. It is a zoonosis with the domestic dog as its 
reservoir (Garifallou et al., 1989; Léger et al., 1988). CL is endemic in the Ionian Islands, 
Crete, Southern Peloponnese and Central Greece, is caused by L. tropica and is 
anthropoonotic without any known animal reservoir host (Igoumenakis, 1930; Malamos, 1947; 
Nicolis et al., 1978; Garifallou et al., 1984). Leishmaniasis has been reported to 5-22.5 % of 
the dogs in the districts of Crete, Athens and the island of Hydra (Desjeux, 1991). In the 
decade of '40 the reports were of about 160 human cases per year. In the '50 about 32 per year, 
in the '60 about 60 cases per year, during 1979-1981 a total of 153 cases, in the  '80 about 50 
cases per year and during 1990-1992 89 cases of VL (Desjeux, 1991; WHO 1993) were 
reported.  
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There is very little information from the Balkan countries of Albania, ex-republics of 
Yugoslavia and Bulgaria. A report exists about a 25-year-old woman of Yugoslavian origin, 
that was diagnosed for CL after a long incubation period of two years (Matzdorff et al., 1997), 
and an other one of a 52 year old janitor from Graz, that was diagnosed for VL after a two 
week vacation in Croatia (Wenzl et al., 1992). There is also a case of VL reported for a girl 
from Albania that was diagnosed in Florence (Calabri et al., 1997). A case from Bulgaria is of 
a 24-year old German man suffering from painful ulcers, that were mimicking a mycotic 
infection. Leishmania major could be detected by PCR investigation (Linss et al., 1998). The 
above mentioned Balkan countries have a lack of medical data not because the disease is not 
endemic there but because of political and geographical changes along with the low level of 
the health system make it impossible to have any kind of epidemiological data at the moment. 
 
Concerning the middle East countries of Turkey, Syria, Lebanon and Israel it is most definite 
that they are strokes from the disease, in different clinical forms. In western Turkey, district of 
Manisa from June 1993 to August 1997, 37 human VL cases were reported and 5.3% (26/490) 
of the dogs, both from L. infantum (Ozbel Y et al., 2000). Infantile Mediterranean VL (L. 
infantum) and anthropoonotic CL (L. major) have long been known to exist in the western and 
south-eastern Turkey, respectively (Ozensoy et al., 1998).  
In Syria 1035 dogs were tested and there were 70 % positive when material from lymph nodes 
was cultured for Leishmania infantum (Dereure et al., 1998). Aleppo is a district endemic for 
L. tropica (Tayeh et al., 1997), while the oriental sore due to L. major is prevalent in the area 
of Damascus (Khiami et al., 1991). 
In Lebanon a total of 81 000 people were examined and 0.18 % of the rural versus 0.41 % of 
the urban population was suffering from CL while VL was practically non-existent in either 
environment (Nuwayri-Salti et al., 2000a, Nuwayri-Salti et al., 2000b). 
Reports from Israel, from an area between Tel-Aviv and Jerusalem, are discriminating L. 
infantum for VL of canines and humans, for the cases of five dogs and one child (Baneth et al., 
2000). CL is mostly due to L. major and is mainly endemic in the Jordan and the Rift valleys, 
while CL due to L. tropica is much less common, almost sporadic (Klaus et al., 1994). Again 
very little is known about the Palestinian areas for the same reasons as with the balcan 
countries. 
 
Egypt is a country that because of its geographical location on the crossroad of the Asian and 
the African continents supplies with reports that discriminate different Leishmania species. 
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Therefore CL was attributed to L. major (Morsy, 1996), VL to L. infantum (Morsy, 1997a), 
while the import of L. tropica from Saudi Arabia is being discussed (Mohareb et al., 1996). 
There is also an interesting case report on DCL (diffuse cutaneous leishmaniasis) not due to L. 
aethiopica as usual, but due to L. major (Morsy et al., 1997b). 
CL is also reported from Libya, 151 cases from the endemic area Al-Badarna in Jabal Nafusa, 
during the time between October 1991 to September 1992 (El-Buni et al., 1996). 
There are recent reports from Tunisia on sporadic VL due to L. infantum MON-1 and MON-
24 isolated from 24 patients (Aoun et al., 2000; Belhadj et al., 2000) which are the main 
responsible agents of the disease, but there are still some old foci of CL caused by L. major 
(Sassi et al., 1999). Some sporadic cases of CL in North Tunisia were identified as caused by 
L. infantum, by the use of a deoxyribonucleic acid probe (Ben-Ismail et al., 1992). 
L. infantum MON-1 and MON-24 have been reported from Algeria, being responsible for 
canine leishmaniasis (Marty et al., 1998). Harrat et al., (1996) note that the human cases of 
leishmaniasis are gradually rising since 1980, reaching the numbers of 1121 cases of VL per 
year and 2000 cases of CL per year. They also isolated L. infantum,  strains (MON-1) and L. 
major (MON-25) from humans, other mammals and sandflies. 
In the emerging epidemic focus of Taza, north Morocco, the isoenzyme characterisation 
revealed the presence of L. tropica (Bichichi et al., 1999). In the same area from October 
1995 to November 1996, 132 human cases were reported due to L. tropica with peculiar 
clinical manifestations as impetiginized, ulcerocrusted and noduloulcerative forms that were 
predominant (61 %) (Chiheb et al., 1999). A seroprevalence study of canine leishmaniasis 
was carried out in five provinces in northern Morocco: Taounate, Al Hoceima, Zouagha 
Moulay Yacoub, Chefchaouen and Ouezzane. A total of 1 013 dogs were screened with IFAT 
and 87 showed antibody titre > or = 100, 83 of them asymptomatic and 4 symptomatic (Nejjar 
et al., 1998). The organism responsible was L. infantum (MON-1). 
 
Going back to the European continent, Spain, Portugal and France are countries presenting 
more or less a similar picture. Both human and canine populations are suffering from 
Leishmania infantum while leishmaniasis is increasing in immunocompetent and AIDS 
patients.  
A survey in red wild foxes in Guadalajara, Spain revealed prevalences of 74 % of 
leishmaniasis (Criado-Fornelio et al., 2000). On an other survey in the Balearic islands 
(Mallorca) out of a total of 112 dogs, 77 % presented immune responses against Leishmania, 
either humoral or cellular (Solano-Gallego et al., 2000). AIDS patients (Reus et al., 1999) and 
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intra venous drug users are suggested as new groups in Spain at high risk (Chicharro et al, 
1999). 
In France the co-infection rates of HIV-Leishmania, rises gradually (Rosenthal E et al., 2000), 
and cutaneous infantile leishmaniasis is no more an unusual phenomena (del Giudice et al., 
1998). In Southern France Leishmania infections were reported in asymptomatic blood 
donors, 76 individuals out of 565 were found seropositive and 9 of these were positive when 
parasite minicircle kinetoplast DNA was amplified via PCR (Le Fichoux et al., 1999). Even a 
unique case of disseminated feline leishmaniasis has been reported from France (Ozon et al., 
1998). In an interesting survey from 1992 (Marty et al.,) in an endemic focus of canine 
leishmaniasis in Alpes-Maritimes, a highly endemic focus of canine leishmaniasis (17 % of 
dogs seropositive in 1985), a total of 237 humans tested for reaction against leishmanin. A 
total of 30 % rected positively. A higher proportion of positive skin tests was obtained in the 
61-70 years age group (62%) than in the younger groups. The proportion of positive tests also 
increased with the duration of living in this locality (22% for less than 5 years; 66% for more 
than 21 years). These data confirm the continuing occurrence of transmission of leishmaniasis 
to human beings in this focus. 
In Portugal leishmaniasis is a zoonosis in most regions where it occurs, with dogs as the main 
reservoirs of the disease, usually suffering from a viscerocutaneous, chronic infection 
(Abranches et al., 1998). From Portugal comes also a recent report of a congenital infection of 
a child from its asymptomatic mother (Meinecke et al., 1999). Pratlong et al., (1995), 
characterised 100 Leishmania isolates by isoenzyme analysis. Many of them were of the 
MON-1 zymodeme, while they all were of L. infantum. Even the dermotropic strains had 
caused VL to the AIDS patients.  
In Italy an epidemiological survey was carried out on the distribution of canine leishmaniasis 
in Western Liguria (Northern Italy). Blood sera collected at different times from dogs were 
subjected to IFAT and ranges of 22.1-30.3 % were positive (Zaffaroni et al., 1999). The 
disease extends to the whole length of the country to the South (Ciaramella et al., 1997). Also 
the infection amongst the HIV patients increases (Gradoni et al., 1996). 
 
Interestingly in a survey that was done in Germany within January 1993 and September 1995, 
revealed that a total of 132 dogs diseased from leishmaniasis. Of those 35 had travelled to the 
endemic areas and 97 were brought to Germany by those endemic countries (Spain, France, 
Portugal, Italy and Turkey) (Gothe et al., 1997). Bogdan (2001) refers to the case of a German 
15 month old child that suffered from leishmaniasis whithout ever entering an endemic area. 
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Meanwhile cutaneous leishmaniasis caused by L. infantum in a horse was reported from South 
Germany (Koehler et al., 2002). 
 
Reviewing the above the Leishmania species that mainly exist in the Mediterranean basin are 
L. infantum, L. major and L. tropica. L. infantum is responsible for the VL, is distributed 
throughout the area and infects humans and dogs. L. tropica is restricted to Middle East, 
Tunisia and parts of Southern Greece and is responsible for anthroponotic CL. L. major 
causes rural VL and is widespread throughout North Africa and Middle East. Some countries 
like Tunisia and Israel are suffering from leishmaniases caused by all three species (Gradoni 
et al., 1984). 
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3. Materials and methods 
 
3.1 Parasites 
The parasites that are isolated from tissue material of a patient (human or canine) after 
growing in grouth medium, are called an isolate. When isolates are further characterised 
(based on molecular or isoenzyme analysis) and certain properties of them are defined are 
called strains. Therefore many different isolates after characterisation may be revealed to 
belong to the same strain or not (WHO, 1990). 
A total of 90 isolates and Leishmania samples were used in this study. 
36 DNA samples derived from isolates of human cases and were well characterised by 
isoenzyme analysis (Table 2). They were obtained from the Institute for Microbiology and 
Hygiene, Charité Hospital, Humboldt University, Berlin, from the Royal Tropical Institute 
Amsterdam and from the Kuvin Centre for the Study of Infectious and Tropical Diseases, 
Hadassah Medical School, Hebrew University Jerusalem.  
Another 30 Leishmania isolates derived from the collection of the Institute for Medical 
Parasitology, Bonn, Germany. 21 were of canine origin, obtained from a previous sample 
collection project between the Institute for Medical Parasitology, Bonn, Germany and the 
Veterinary Faculty, Aristotelian University, Thessaloniki, Greece. They were isolated from 
dogs in Northern Greece but no clinical history was available. 
Another 9 isolates were obtained from human patients who visited the Institute for Medican 
Parasitology in Bonn within the last 10 years. The patients had previously travelled to 
Ethiopia, Iran, India, Sudan, Brazil, Mexico and Spain. Inially 16 isolates were available but 
only the above mentioned 9 of them were successfully recovered in cultured since most of 
them were kept in liquid nitrogene for long time without intermediate passage. 
 
 
 
 36 
Table 2. Characterised human Leishmania strains used in this study. 
 
Isolate 
Code 
WHO Code (based on 
isoenzyme analysis) 
Taxon Origin Patient’s 
clinical 
picture 
INF-01 MHOM/TN/80/IPT1a infantum Tunisia VL 
INF-02 MHOM/FR/62/LRC-L47 infantum France VL 
INF-03 MHOM/ES/87/Lombardi infantum Spain CL 
INF-04 MHOM/CN/78/D2 infantum China VL 
INF-05 MHOM/FR/80/189 infantum France VL 
INF-06 MHOM/FR/80/189 infantum France VL 
INF-07 MHOM/IL/89/LRC-L571 infantum Israel NK 
INF-08 Human patient isolate, 
identified at the Charitè. 
infantum possibly 
Turkey 
NK 
INF-09 MCAN/PT/94/IMF193 infantum Portugal NK 
INF-10 MCAN/TR/96/EP16 infantum Turkey NK 
INF-11 MHOM/TR/94/EP3 infantum Turkey NK 
INF-12 MCAN/IL/94/Robi infantum Israel NK 
INF-13 MCAN/IL/96/Skidro infantum Israel NK 
INF-14 MCAN/IL/96/LRC-L695 infantum Israel NK 
INF-15 MCAN/IL/96/LRC-L709 infantum Israel NK 
INF-16 MCAN/IL/97/LRC-L716 infantum Israel NK 
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INF-17 MCAN/IL/97/LRC-L717 infantum Israel NK 
INF-18 MCAN/IL/97/LRC-L718 infantum Israel NK 
INF-19 MCAN/ES/??/Whiskey infantum Spain NK 
CHA-01 MHOM/BR/74/PP75 a chagashi Brazil NK 
DON-01 MHOM/IN/80/DD8a donovani India NK 
DON-02 MHOM/KE/83/NLB189 donovani Kenya PK 
DON-04 MHOM/KE/85/NLB323 donovani Kenya NK 
DON-06 MHOM/SD/75/LV139 donovani Sudan CL 
DON-08 MHOM/SD/68/1S donovani Sudan VL 
DON-10 MHOM/IN/71/LRC-L51a donovani India VL 
AET-03 MHOM/ET/94/Abauye aethiopica Ethiopia DCL 
TRO-02 MHOM/SU/74/SAF-K27 a tropica Sudan CL 
TRO-22 MHOM/TR/95/URFA7 tropica Turkey CL 
MAJ-01 MHOM/SU/73/5ASKH a major USSR CL 
MAJ-03 MHOM/SD/90/Sudan3 major Sudan NK 
MEX-03 Isolate from a Dutch patients 
identified at the Charitè 
mexicana ? NK 
AMA-01 MHOM/BZ/73/M2269 a amazonensis Belize NC 
BRA-01 MHOM/BR/75/M2903 a brasiliensis Brazil NC 
GUA-01 MHOM/BR/75/M4147 a guyanensis Brazil NC 
PAN-01 MHOM/CR/87/NEL3 panamensis Costa Rica 
Comanne 
NC 
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VL: visceral leishmaniasis; CL: Old World cutaneous leishmaniasis; NC: New World 
cutaneous leishmaniasis; MCL: mucocutaneous leishmaniasis; PK: Post-Kala Azar; NK: not 
known  a :WHO reference strains; where nothing is filled in the patient’s clinical picture 
means that there is no data about it. 
 
All unidentified isolates were given a code for facilitation purposes. So the 21 canine isolates 
from northern Greece were coded as S(d)1 (sample from dog 1) from S(d)1 to S(d)21. The 9 
human ones were coded from S(h)22 to S(h)30 (as sample from human). 
In addition 24 DNA samples from German dogs were included. The dogs were infected with 
Leishmania while travelling in South Europe (mostly Italy and Spain). Dr S. Steuber, 
Bundesinstitut für Gesundheitlichen Verbraucherschutz und Veterinärmedizin, Berlin, kindly 
provided DNA samples that were extracted from infected bone marrow (21), lymph nodes 
(1) and blood (2) of these dogs. Those samples were coded as BS1-BS24 (BS: biological 
sample). 
Epigrammatically, the total number of samples used for this study was 66 various 
Leishmania isolates of canine and human origin and 24 total DNA samples of Leishmania 
infected tissue material. 
 
3.2 Parasite culture 
The 21 dog isolates from Northern Greece and 16 human isolates from the collection of the 
Institute for Medical Parasitology in Bonn were cultured in RPMI-1640 medium (Sigma No. 
R 6504 with L-glutamine). 2.0 g/l of sodium bicarbonate or 26.7 ml/l of sodium bicarbonate 
solution (7.5% w/v) were added to the prepared medium. Finally, the medium was 
supplemented with 15% foetal calf serum (Seromed) and according to Howard et al., 1991b, 
5% human urine from a volunteer and incubated at 26°C after inoculation with parasites. 
For a rapid and reproducible growth in culture, a ratio of no more than 1 vol. of inoculum to 
4 vol. of fresh medium was required. Most rapid growth in new medium was observed when 
sluggish or largely immotile promastigotes were innoculated. 
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The cultures were harvested at an approximate density of 2x106 parasites/ml. They were 
washed twice in phosphate buffered saline (PBS) and processed for the DNA extraction. 
Parasites were successfully cultured from all 21 canine isolates but only from 9 of the 16 
human cases (see above). 
 
 
3.3 Parasite preservation 
The parasites were mixed with medium (RPMI, 10 % FKS), sterile glycerine (Roth, 7530.1) 
and subjected to a programmable freezing uni, freezing at about 1°C/min to -70°C. The 
parasites were held in that temperature overnight and then taken to –70°C in liquid nitrogen, 
where they were kept permanently.  
An alternative method that was used and worked very well was keeping the parasites with 
the mixed glycerine at 4°C for 2-6 h, then transferring them to –20 or –30 °C for 24 h 
subsequently to –80°C for 36 h and finally to liquid nitrogen. To recover the organisms prior 
to transfer into fresh medium, the cryotube was plunged into a water bath at 25°C until the 
parasites were thawed. 
 
 
3.4 DNA extraction (according to Schönian et al., 1996) 
The parasites (300 µl) were resuspended in lysis buffer (50mM NaCl, 10mM EDTA, 50mM 
Tris-HCl, pH 7.4). Sodium dodecylsulphate was added to a final concentration of 0.5 % w/v 
and the solution was shaked well until it became viscous. Proteinase K and ribonuclease 
were added to final concentrations of 100 µg/ml each and the mixture was then incubated 
overnight at 60°C.  
The DNA was extracted using an equal volume of buffered phenol, followed by an extraction 
with phenol-chlorophorm-isoamyl alcohol mix (v/v 25:24:1). One volume of chlorophorm-
isoamyl alcohol was added, and the mixture was vortexed and centrifuged at 3000 rpm 
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(Heraeus Sepatech Biofuge 13R) for 10 min. Adding 1/10 of the volume of 3 M sodium 
acetate, pH 5.2, and one volume of isopropanol precipitated the DNA.  
The mixture was left for at least 60 min at 4°C and centrifuged at 8000 rpm for 15 min. The 
supernatant was rejected and an equal volume of 70 % ethanol was added. The mixture was 
again centrifuged and the supernatant was discarded. The resulting DNA was dried in a 
vacuum dessicator and resuspended in 200-500 µl TE buffer [10mM Tris (pH 7.5), 1mM 
EDTA (pH 7.2)].  
Extraction efficiencies and qualities were checked on 1 % agarose gel and DNA 
concentration and purity were estimated by measuring the optical densities at 260 and 280 
nm. 
 
 
3.5 Diagnosis and differentiation 
The following techniques were employed for diagnosis and differentiation of the different 
isolates and samples. 
 
3.5.1 Diagnosis of visceral leishmaniasis using PCR 
 
In the current study a PCR technique was employed which was originally developed by 
Meredith  et al. (1993) for amplification of Leishmania DNA directly in biological materials. 
A 560 bp variable fragment of the ssu rRNA gene of Leishmania spp. is amplified in this 
assay. The protocol used in this study is based on Omran et al. (1997, 1998) and has been 
applied after personal communication with O. F. Omran.  
 
Five microliters of isolated DNA were added to 45 µl of a PCR mixture containing 20 mM 
Tris-HCl; 50 mM KCl; 4mM MgCl2; 250 mM of each deoxynucleoside triphosphate; 0.5 U of 
Taq polymerase and 100 pmol of both primers 174 (5'-GGTTCCTTTCCTGATTTACG-3'), 
and 798 (5'GGCCGGTAAAGGCCGAATAG-3'). Samples were initially denatured at 94° C 
for 10 min and 38 cycles followed consisting of denaturation at 94° C for 75 sec, annealing at 
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60° C for 1 min, and extension at 72° C for 2 min. A final extension in 72° C for 3 min 
followed. 
 
Amplification reactions were visualised on a 2 % agarose gel, and a 100 bp DNA ladder was 
used as molecular weight standard. Samples were scored positive when the PCR product of 
560 bp could be detected. 
 
The 24 total DNA samples (BS1-BS24) of Leishmania infected tissue material provided by 
Dr. S. Steuber (Bundesinstitut für Gesundheitlichen Verbraucherschutz und Vterinärmedizin, 
Berlin), were processed through that PCR. 
 
 
3.5.2. Amplification and restriction enzyme digestion of the ITS region 
 
The following specific oligonucleotide primers were used to amplify the Internal Transcribed 
Spacer (ITS) region which is lying between the small subunit rRNA and the large subunit 
rRNA genes and includes the 5.8S RNA gene (Innis et al., 1990; Schönian et al., 2000): 
LITSR (5’-GTG GAT CAT TTT CCG ATG) and LITSV (5’-ACA CTC AGG TCT GTA 
AAC).  
Amplification reactions were performed in volumes of 50 µl containing 20 ng template 
DNA, 1.5 mM Mg++; 20 mM Tris/HCl pH 8 and 50 mM KCl2, 200 mM each of dATP, 
dCTP, dGTP and dTTP (Pharmacia Biotech), 25 pmol of each primer and 2U Taq DNA 
polymerase (Gibco BRL).  
Samples were overlaid with sterile, light mineral oil and amplified as follows: initial 
denaturation, 2 min at 95°C; denaturation, 20 sec at 95°C; annealing, 60 sec at 51°C; and 
extension, 60 sec at 72°C; 35 cycles were run. This was followed by a final extension cycle 
of 6 min at 72°C. PCR products were checked on a 1 % agarose gel and kept at 4°C until 
processed.  
Restriction fragment length polymorphism (RFLP) patterns were produced when the PCR 
products were digested with restriction enzymes HaeIII and CfoI. Each reaction was loaded 
with 17µl PCR product, 10 U HaeIII (Boehringer Mannheim) or 10 U CfoI (Boehringer 
Mannheim) and 2 µl 10x Buffer Blue or 10x SuRE/Cut buffer L (Boehringer Mannheim) 
respectively. The mixtures were vortexed and incubated for 2 h at 37°C. Then they were 
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stored at 4°C until run in 1 % agarose gels for 2 h at 3 V/cm in 0.5 x TBE buffer (0.045 M 
Tris-borate, 1 µM EDTA). Digestion products were detected after staining the gels with 
ethidium bromide. 
The 30 Leishmania [S(d)1-S(d)21 and S(h)1-S(h)9] isolates from the collection of the 
Institute for Medical Parasitology, Bonn, Germany were processed through the above. 
Isolates from the 36 well characterised isolates were used as standard controls. 
 
 
3.5.3 PCR fingerprinting with single arbitrary primers 
 
The following oligonucleotides were used as single primers in the PCR experiments: the 
simple repeat sequences (GTG)5-(5’-GTG GTG GTG GTG GTG), (GACA)4-(5’-GAC AGA 
CAG ACA GAC A) (Ali et al., 1986) the core sequence of phage M13 (5’-GAG GGT GGC 
GGT TCT) (Huey et al., 1989), and the T3B oligonucleotide which was derived from 
intergenic tRNA genes' spacers (5’-AGG TCG CGG GTT CGA ATC C) (McClelland et al., 
1992.  
 
Amplification reactions were performed in volumes of 50µl containing: 10-50 ng template 
DNA, 20mM Tris/HCl, pH 8.0, 50 mM KCl2, 4.5 mM Mg++, 200 mM each of dATP, dCTP, 
dGTP and dTTP and 1.5U Taq DNA polymerase. The primers (GACA)4 and M13 core were 
added at a final concentration of 25 pmol per assay and the (GTG)5 and T3B were added at 
concentrations of 10 and 5 pmol per assay, respectively.  
 
Samples were overlaid with sterile, light mineral oil and amplified as follows: initial 
denaturation, 2min at 95°C; denaturation, 20 s at 95°C; annealing, 30 s at 50°C for the 
(GTG)5 primer, 60 s at 50°C for the (GACA)4 primer, 60 sec at 50°C for the M13 core 
primer, 32 s at 52°C for the T3B primer; extension, 80 s at 72°C for the (GTG)5 and T3B 
primers and 20 sec at 72°C for the (GACA)4 and  M13 core primers; a total of 32 cycles was 
run for the (GTG)4 and T3B primers whilst 35and  27 cycles were run for the (GACA)4 and 
M13 core the primers, respectively. A final extension for 6 min at 72°C followed and the 
reaction tubes were held at 4°C prior to analysis.  
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The samples were concentrated in a Speed Vac to an approximate volume of 20 µl and 
subjected to electrophoresis in 1.2 % agarose gels for 5 h at 3 V/cm in 0.5 x TBE buffer. The 
amplification products were visualised under UV light after staining the gels with ethidium 
bromide. 
 
The 30 Leishmania isolates [S(d)1-S(d)21 and S(h)1-S(h)9] from the collection of the 
Institute for Medical Parasitology, Bonn, Germany were processed through the above. 
Isolates from the 36 well characterised isolates were used as standard controls. 
 
 
3.5.3.1 Computer-assisted data analysis 
 
After staining the gels were photographed, and the DNA fragments were sized and compared 
with the use of scanner-associated computer hardware and software (RFLPscan, version 
2.01, Scanalytics CSP Inc., Bilerica, MA, USA). The similarity indices representing the ratio 
of shared bands over total bands within two lanes being compared during the matching 
operation were estimated for the different Leishmania species tested as well as for isolates 
belonging to the same species. Distance matrices based on N (N - 1)/2 pairwise comparisons 
between N data sets were calculated and evolutionary trees were constructed by UPGMA 
(unweighted pair group method using arithmetic averages) which is a cluster based analysis 
(Sneath et al., 1973; Saitou et al., 1987) using the Treecon programme (Van de Peer et al., 
1993). The genetic distance (Gdxy) was computed according to Nei et al., 1979, as 
following: 
 
Gdxy = 1-  2Nxy 
                -------- 
                Nx+Ny 
 
Nxy stands for the number of bands shared in lines x and y, Nx for the number of fragments 
in line x and Ny for the number of fragments in line y. 
 
Bootstrap analysis was also used to place confidence intervals on phylogenies. This is a kind 
of statistical analysis to test the reliability of certain branches in the evolutionary tree (Efron 
et al., 1983; Felsenstein, 1985; Swofford et al., 1996).  It involves resampling one's own 
data, with replacement, to create a series of bootstrap samples of the same size      as the 
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original data. Bootstrap values at a branching point denote the number of bootstrap trees 
comprising a cluster of the same composition. In our case a sufficient number of 100 replicas 
performed bootstrap analysis and bootstrap values of 75 minimum were concidered well 
supported for the respective branch. 
 
 
  
3.6 PCR-SSCP 
 
SSCP was used to screen for polymorphisms in ITS1 products as well as in anonymous PCR 
markers.  
 
All PCR reactions were first optimized using the DNA from the WHO reference strains and 
from some of the L. infantum and L. donovani strains identified earlier by Schönian et al., 
(1996). Afterwards a total of 45 samples were processed through it. The PCR products were 
going through the SSCP at the Hoefer SE400 system vertical electrophoresis chamber system 
(Hiss et al., 1994) in a cold room. When the electrophoresis was finished the gels were silver 
stained and fixed between sheets of foil. 
 
 
3.6.1 PCR of the ITS1 region 
The ITS1 region is lying between the small subunit rRNA and the 5.8S RNA genes. For the 
amplification of this region the primer pairs LITSR (5´- CAG GAT CAT TTT CCG ATG) 
and L5.8S (5'- TGA TAC CAC TTA TCG CAC TT) (Schönian, personal communication) 
were used. Each 50 µl assay contained 20 ng DNA, 25 pmol of each primer, 200 µMol of 
each dNTP, 1.5 Mol Mg++ and 2 U Taq DNA polymerase. A total of 32 cycles followed; 
denaturation for 20 sec at 95°C, annealing for 30 s at 53°C and extension at 72°C for 60 s. 
The initial denaturation was at 95°C for 2 min and the final extension at 72°C for 6 min. The 
product was kept at 4°C until run at the SSCP. 
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3.6.2 PCR reactions of the codominant markers 
Schönian and co-workers at the Institute for Microbiology and Hygiene, Charité Hospital, 
Humboldt University, Berlin, Germany, have designed codominant PCR markers able to 
detect both alleles in a diploid organism, able to dectect intraspecies variations in Leishmania 
spp. from randomly amplified monomorphic DNA (Schönian et al., 2000). For the current 
experiments 9 primer pairs annealing to anonymous DNA sequences of the L. donovani 
complex (L. donovani, L. infantum, and L. chagasi), were used.  
The primer pairs that were used for the reactions are listed in Table 3. 
 
Table 3: Primer sequences used for the amplification of codominant anonymous markers for 
the L. donovani complex. 
Marker F: 5’-3’ 
forward primer 
R: 5’3’ 
reverse primer 
Expected 
product (bp) 
L1012 ACA CAC AGG CAT GTG GGT ACG TAC ACT CCG TTT GGT TTC CG 200 
L0720 CAA CGT ATG CGG TTT GTC TC GAG TGC GCA TCT ACT AAT CG 300 
L0510 ATA GGT TAA CGG CAA CGC AC TGA CAG AGA CAC ACA ACG AC 250 
L0114 CTA CCA AGA AGG GTG GCA AG GGT GCA GTA CTC GTA CCT AC 200 
L1112 TGC CGA GAG GAG GGA AAG GAT ATG CAC ACG CAC AAA GC 350 
L0413 CTC ACG CTT TGT GCT TGT GT CAA CAA GGC GTA TTT CCA CG 300 
L0110 GGC AAA GAA AAA GAG CaG CG CCT GTC GTG CGT TGA ATA TC 550 
L1119 CCT CTA TTC CAC ATA TTT CT AAT CAG CAA GGA CAC CA 400 
 
 
Amplification reactions were performed in volumes of 50 µl containing 20 mM Tris-HCl, 50 
mM KCl, 1U Taq DNA polymerase, 50-200 mM each of dATP, dCTP, dGTP and dTTP, 1-
1.5mM Mg++, 10-60 pmol/reaction of each primer and 6-20 ng template DNA (details listed 
in Table 4). 
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Table 4: Amplification reactions with the codominant markers for L. donovani complex 
(technical data). 
 
Primers dNTP's 
(mM of 
each) 
Mg++ 
(mM) 
Primers 
(pmol of 
each) 
DNA 
(ng) 
Annealing 
temperatures 
No of cycles 
L1012 150 1.5 30 15 50 34 
L0720 200 4 30 20 52 34 
L0510 75 1.5 30 10 54 34 
L0114 200 1.5 60 8 51 34 
L1112 50 1.5 15 6 55 32 
L0413 50 1 10 6 54 30 
L0110 50 1.2 13 6 51 32 
L1119 100 3 50 10 47 34 
 
 
Samples were overlaid with sterile, light mineral oil and amplified as follows: initial 
denaturation, 3 min at 95°C; denaturation, 1 min at 94°C; annealing, 50-55°C for 30 s; 
extension, 1 min at 72°C; a total of 32-34 cycles were run. A final extension for 6 min at 
72°C followed and the reaction tubes were held at 4°C prior to analysis (details in the table 
4).  
 
Amplification products were subjected to electrophoresis in 1.5 % agarose gels for 2 h at 5 
V/cm in 0.5 x TBE buffer and visualized under UV light after staining the gels with ethidium 
bromide. The PCR products were 200-600 bp in size (Table 3). 
 
 
3.6.3 Preparation of the SSCP gel 
 
The gel matrix for the SSCP (MDE-gel, FMC-Bioproducts) was 0.8 µm thick and was 
prepared the night before the run and was left to stand overnight. Both glass plates were first 
washed twice with distilled water and once with ethanol. The plate which was to be removed 
leaving the gel to be stained on the other plate, was sprayed with Acrylease (Stratagene). A 
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total of 100 ml gel consisted of  25 ml MDE-gel, 6 ml 10XTBE, 69 ml bidest, 40 µl TEMED 
and 400 Ml 10 % APS. 
 
Each slott was loaded with 2 µl stop solution, 2 µl SDS, 10% EDTA and at least 10-20 µl 
PCR product. The mixture was previously denatured at 98°C for 15 min and immediately 
transferred into ice water (0°C) for at least 10 min. 
 
Expected fragments of 200-400 bp in size were electrophoresed for 3 h at 30 mA, while 
bigger fragments were separated overnight at 6 mA using the Hoeffer 600 system (Pharmacia) 
in a cool room (4°C). Sandwich gels were prepared as well using a divider plate to run a 
double number of samples. Consequently the sandwich gels were electrophoresed at doubling 
current compared to the respective single ones but for the same time. 
 
 
3.6.4 Silver staining of the SSCP gel (Budowle et al., 1996)  
 
First the gel was fixed in 1 % nitric acid for 10-15 min. Then it was briefly rinsed with double 
distilled water and stained for 20-25 min in 0.2% Silver nitrate solution. After washing for 5-
10 min with double distilled water the gel was developed in 0.28M sodium carbonate plus 
formaldehyde (37 %) (fresh solutions always). That was followed by another washing in 
double distilled water and by fixation in 10% acetic acid for 5 min. After washing in double 
distilled water the gel was neutralised for 30 min in a solution containing 20 % ethanol and 10 
% glycerol, and brought between two cellophane replacement sheets (Roth). It was left to dry 
on air, while held by plastic frames. 
 
The Leishmania isolates from the collection of the Institute for Medical Parasitology, Bonn, 
Germany that were identified via PCR-RFLP and PCR fingerprinting with single arbitrary 
primers, belonging to the L.donovani complex [S(d)1-S(d)21 S(h)27 and S(h)29], along with 
the standard isolated of L.donovani complex, were processed through the PCR-SSCP. 
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3.7. Index of reagents, disposables, machinery, buffers and solutions. 
 
3.7.1 Index of reagents 
 
Company Reagents Catalogue number 
Boehringer Mannheim Cfo I 693 936 
 Hae III 
 
693 936 
Fluka TEMED 
 
386451190 
FMC-Bioproducts MDE Mutation Detection Gel 
Solution 
 
50621 
Ammonium peroxisulfate 
(APS) 
5523UA 
DNA marker 100 bp 15615-016 
DNA marker 123 bp 15613-011 
DNA marker 1 kb 15628-050 
Gibco BRL 
PCR kit 
 
18038-026 
Acetic acid 634 
Chloroform 1.02431 
Ethanol 1.00983.2511 
Formaldehyde 1.04003 
Isoamyl alcohol 977.1000  
Silver nitrate 101510.0050 
Sodium acetate 15.0100 
Sodium carbonate 1.06392.1000 
Sodium chloride 6404.1000 
Merck 
Sodium dodecyl sulfate 
(SDS) 
 
1.00983.2511 
Peqlab MoSieveTM-Agarose MS500 35-3010 
 peqGOLD Universal agarose 35-1020 
 49 
 Pharmacia Biotech dNTP set, ultrapure 
 
27-2035-01 
Qiagen PCR purification kit 
 
28104 
Boric acid 69.43 
Glycerine 7530.1 
Roth 
Phenol (buffered) 
 
0038.1 
Seromed Foetal calf serum 
 
S0115 
Sigma EDTA ED-255 
 Ethidium bromide E-1510 
 Penicillin/Streptomycin 
solution 
P-0906 
 Proteinase K P-6556 
 Ribonuclease A R-6513 
 RPMI-1640 R-6504 
 Sodium carbonate S-8875 
 Trizma base 
 
T-8524 
Stratagene Acrylease nonstick plate 
coating 
 
300132 
TIB MOLBIOL 
Syntheselabor, Berlin 
Primers  
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3.7.2 Index of disposables 
 
Company Product Catalogue number 
Eppendorf Safe lock tubes 2 µl 0030120.094 
 
Millipore 0.22 µm filter units 5VGSB1010 
 
Nunc Tubes fur cell culture 156758 
 
Peqlab Flat cap PCR tubes 0.5 ml 82-0350 
 
Glass plates for Hoefer 600, 
18x16 
80-6178-99 Pharmacia Biotech 
Glass plate divider 80-6490-20 
 
Polaroid (Balmes & 
Gondorf) 
 
Polaroid film, 665 PIN  
Roth Cellophan Ersatzfolien  K423.1 
 
Schleicher & Schüll Sterile filter holders 0.2 µm FP030135 
 
Sigma Microcapillary round tips 
Tips 0.5-10 µl aerosol stop 
 
T2531 
P8312 
Central supply department 
of the university Clinics of 
the Reinische Friedrich-
Wilhelm University in 
Bonn, 
Tips 0.5-10 µl  
 
Tips 10-100 µl  
 
Tips 100-1000µl 
32353379 
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3.7.3 Index of machinery 
 
Machinery Company 
Camera Polaroid MP-4 Lnd camera 
Centrifuge Heraeus Sepatech Biofuge 13R 
Centrifuge Heraeus Varifuge 3.0R 
Electrophoresis chambers Renner 
Electrophoresis chamber OWL model A1 
Gel drying frames, 24x24 cm Roth  
Pipette 0.1-1 µl Eppendorf 
Pipette 1-10 µl Eppendorf 
Pipette 10-100 µl Eppendorf 
Pipette 100-1000 µl Eppendorf 
Power supply Biometra standard Power pack P250 
Power supply Pharmacia biotech EPS 3500 
Programmable freezing unit REVCO, ultra low temperature 
UV transilluminator Biometra  
Speed vac Christ RVC 2-18 
Thermocycler T3 Thermocycler-Biometra 
Vertical slab gel unit, Höfer Model SE400 Pharmacia Biotech 
Water bath Memmert 
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3.7.4 Solutions and buffers 
 
Ethanol-Glycerol solution Ethanol 20%, Glycerol 10% in aqua bidest 
Ethidium bromide solution stock solution 10 mg/ml; working solution 0.5 
µg/ml 
 
Leishmania lysis buffer 50 mM NaCl, 10 mM EDTA, 50 mM Tris-HCl, pH 
7.4 
 
NaCO2-Formaldehyde sodium carbonate 29.6 g/l; 0.5 ml formaldehyde  
 
Phenol/Chloroform/Isoamyl 
alcohol  
phenol/chloroform/isoamyl alcohol in volumes 
25:24:1 
 
RPMI-1640 medium RPMI 1640; 2 gr sodium bicarbonate; 15% foetal 
calf serum 
 
Sodium acetate Sodium acetate 3M; autoclave 
 
Stop solution (loading 
buffer) 
30 % glycerol; 0.25 % bromophenol blue; 0.25 % 
xylene cyanol FF; 10 mM EDTA 
 
TBE buffer trizma base 108 g/l; boric acid 55 g/l; EDTA 20 
mM (pH 8) 
 
TE buffer trizma-base (pH 7.5) 10 mM; EDTA (pH 7.2) 1mM  
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 4. Results 
 
4.1 Parasites 
 
All 21 canine isolates collected in Northern Greece (S(d)1-S(d)21) could be successfully 
cultured. However living parasites could be collected only from 9 (S(h)22-S(h)30) of the 16 
human isolates which were under cryopreservation for the last 7-12 years without subsequent 
passage. Motile parasites could be seen in the canine isolate cultures after 3-4 days and they 
could be harvested after 7 days, while in the human isolates, it would last much longer. In one 
of the human isolates, living parasites were first observed after two months. In general the 
cultures were left in the incubator until parasites or bacterial and/or fungal contamination 
were seen in the microscope, trying to exhaust all time limit. 
 
The long term maintenance of leishmanial parasites by serial subculture in vitro is 
problematic since promastigotes tend to lose their ability to transform into metacyclic forms 
when cultured for a long time (Evans et al., 1989). 
 
 
4.2 Diagnosis of visceral leishmaniasis using PCR 
 
This diagnostic PCR was described in §3.5.1. The isolates that were scored as positive, 
yielded a product of 560 bp and were all the L. infantum, L. chagasi from Table 2, the isolates 
S(d)1-S(d)21, S(h)27, S(h)29 and the 24 (BS1-BS24) samples from German dogs that were 
infected with Leishmania while travelling in South Europe. The latter 24 were clinical 
samples from dogs, that had travelled to South Europe and they were diagnosed with 
leishmaniasis using another PCR method at the Bundesinstitut für Gesundheitlichen 
Verbraucherschutz und Veterinärmedizin in Berlin. 
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4.3 RFLP analysis of the ITS region 
 
All the 21 canine (S(d)1-S(d)21)and 9 human isolates (S(h)22-S(h)30) were processed 
through the PCR amplifying the ITS region (see § 3.5.2). After diggestion with the restriction 
enzymes HaeIII and CfoI, the patterns were checked after gel electrophoresis. Reference 
strains listed in Table 2 (§3.1) were always used as controls. 
 
The 21 canine isolates after the digestion with HaeIII gave a pattern of three bands 
corresponding to an average molecular weight 89 bp, 236 bp and 690 bp (examples in Figure 
2). That was exactly the RFLP pattern that all the characterised L. infantum, L. donovani and 
L. chagasi listed in Table 2 gave. 
 
Similarly homogeneous results were produced after the digestion of the above mentined 
isolates with CfoI. The resulting pattern was comprised of five bands of average sizes of 345 
bp, 305 bp, 158 bp, 94 bp and 71 bp (examples in Figure 3). 
 
Comparing the patterns of the isolates S(h)22-S(h)30 with patterns of different reference 
strains it was possible to identify them at the species or complex level listed in Table 5. 
 
 
Table 5: Identification of  S(h)22-S(h)30 at the species/complex level by RFLP analysis of 
the ITS region in comparison to reference strains. 
 
Isolate codes Corresponding reference complex or strain  
S(h)22 TRO-02, TRO-22 
S(h)23 AET-03 
S(h)24 TRO-02, TRO-22 
S(h)25 TRO-02, TRO-22 
S(h)26 L.brasiliensis complex 
S(h)27 L.donovani complex 
S(h)28 L.brasiliensis complex 
S(h)29 L.donovani complex 
S(h)30 L.brasiliensis complex 
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4.4 PCR fingerprinting with single arbitrary primers 
 
All the isolates listed in Table 2, the 21 canine isolates (S(d)1-S(d)21) from Northern Greece 
and the 9 human isolates (S(h)22-S(h)30) were processed through fingerprinting PCR (§ 
3.5.2), using all primers [T3B, (GACA)4, M13, (GTG)5]. Figures 4 to 7 show selected 
examples of fingerprinting patterns using the above mentioned primers. 
 
All Leishmania isolates were repeatedly tested. The polymorphic fragment patterns were 
reproducible with slight variations in the intensity and occasionally in the banding pattern. 
The latter was observed in one or two bands, usually the very large (>3 kb) and very small (< 
250 bp) ones. Those isolates which were prone to variation were excluded from the analysis. 
Faint bands were considered only if they were consistently found in different experiments. 
Bands of higher intensities, might be due to the amplification of repetitive sequences, the 
influence of neighbouring sequences on annealing to the target sequence or might have been 
generated because of a lower degree of mismatch between primer and target sequence (Welsh 
et al., 1991; Godwin et al., 1991). 
 
Distinctive sets of amplification products were observed for each taxon and for every sample 
depending on the taxon it belonged to. The discriminating capacity of the primers were 
similar. With the primer M13 core sequence, each isolate yielded 11 to 31 bands ranging 
between 3300 bp and 300 bp; with the primer T3B 9 to 26 bands of 3390 bp to 445 bp; with 
the primer (GACA) 4 11 to 25 bands ranging between 3600 bp and 360 bp and with the primer 
(GTG) 5, 16 to 28 bands of a molecular weight 3550 bp to 400 bp. The main grouping was 
made under each primer so that information could be collected for each isolate prone to 
variation. Therefore under each primer all amplification products were scored for each isolate 
according to molecular weight. In the end for each group  of amplification products a matrix 
was produced comprised not anymore from particular weight corresponding to the produced 
bands but from the two numbers 1 or 0 corresponding to scoring positive or negative the 
production or not of each possible band for each isolate. 
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4.4.1 Computer assisted analysis with the TREECON for Windows v.1.3b 
The results went through the computer-assisted analysis (§ 3.5.2.1) and the produced matrices 
were analysed by TREECON for Windows (version 1.3b, 1998) whereof evolutionary trees -
dendrogrammes- were constructed and produced (Van de Peer et al., 1994; http://bioc-
www.uia.ac.be/u/yvdp). 
4.4.1.1. Dendrogramme produced after PCR with the primer (GACA)4 
The tree produced by this primer (Dendrogramme 1) is very well supported by bootstraping to 
the clades of the species identification. Especially good are the bootstraping values within the 
L. donovani complex (bootstraping values of 97-99) and the L. brasiliensis complex 
(bootstraping values of 93-100). Within the L. infantum isolates there is one distinct grouping 
of the Greek isolates while the rest of the L. infantum isolates are constituting the second 
group without any particular subgrouping. The later is very well supported by bootstrap value 
(99). 
4.4.1.2. Dendrogramme produced after PCR with the primer (GTG)5 
The (GTG)5 primer once again gives identical patterns for all the greek isolates. The 
Dendrogramme 2 shows very similar results to Dendrogramme 1, with bootstrap values 
supporting very well the complex clades (bootstraping values of 89-100) and the L.infantum 
species clade (bootstraping value of 93). Unfortunately the PCR with this primer could not be 
applied to all samples because of technical reasons. Therefore it was not taken into accont 
when the matrices were combined to get more general results. Nevertheless the results that 
were obtained in Berlin where the method is routinely established are reported and discussed. 
4.4.1.3. Dendrogramme produced after PCR with the primer M13 
The M13 primer is supported very well by the bootstraping the species identification. 
According to Dendrogramme 3 there is a grouping of the Greek isolates, and altogether they 
are according with some of the L.infantum isolates coming from Spain, Tunisia, Portugal, 
France, Turkey and China. There is also a major grouping of the Israeli isolates together with 
isolates from Turkey, Spain and Portugal. 
4.4.1.4. Dendrogramme produced after PCR with the primer T3B 
According to Dendrogramme 4, with the primer T3B the Greek L.infantum isolates had 
identical patterns when using primer T3B. Patterns are supported with high bootstrap values 
(more that 50). The rest of the Mediterranean isolates represents the majority of the second 
grouping. Within the second grouping there are the isolates coming from China, France and 
Spain belonging to one subgroup and those from Israel, Turkey and Portugal belonging to 
another. The Greek isolates were homogenous while others showed some differences. 
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Nevertheless the group of INF-15 and INF-17, the group of INF-11, INF-13, INF-14, INF-09 
and INF-10 and the group CHA-01 and S(h)29, produced identical patterns within the group. 
4.4.1.5. Dendrogramme produced after combination of the matrices produced 
through primers M13, T3B and (GACA)4 
The results from the three primers M13, T3B and (GACA) 4 were combined to the 
construction of the evolutionary tree 5 (Dendrogramme 5), where the results are a 
combination of what was shown above. The three complexes of L. donovani, L. brasiliensis 
and L. mexicana are clearly distinct. Samples S(d)1-S(d)21 belong to L .infantum, S(h)22-
L(h)25 belong to L. tropica or L. aethiopica, S(h)26 and S(h)28 to L. guyanensis, S(h)27 to L. 
donovani, S(h)29 to L. chagasi and S(h)30 to L. brasiliensis. The Greek L. infantum isolates 
are grouping together. Israelian isolates are also forming a cluster, including the Turkish 
isolates in their group. The bootstrap values are very high to the clades of the complex, 
species and also the grouping of the L. infantum strains. There are three clusters of L. 
infantum formed with excellent statistical support (bootstrap values 99-100), one with the 
Greek canine isolates, one with the isolates from Turkey and Israel and a third with the rest of 
the L. infantum isolates.  
4.4.1.6. Dendrogramme produced for the L.donovani complex, combining the 
matrices produced from the primers M13, T3B and (GACA) 4 
Dendrogramme 6 was made combining the PCR results from the primers M13, T3B and 
(GACA) 4, for the L. donovani complex (L. infantum, L. chagasi and L. donovani) reference 
strains and the samples S(d)1-S(d)21 that were identified as L.infantum. The bootstrap values 
of the clades that lead to species are high (72-95) as well as those of the intaspecies grouping 
of the L. infantum (99-100). L. infantum and L. donovani are clearly seperable with very good 
statistical support. The Greek isolates on the one hand are grouping together and so do those 
from Israel. The other isolates are distributed between those two groups. The two isolates 
from Turkey, one canine and one human (INF-10 and INF-11), and the geographically 
heterogenous isolates INF-05, INF-04, INF-01 and INF-03 that are coming from France, 
China, Tunisia and Spain, respectively, are grouping together. 
4.4.2. Taxonomic identification of the tested samples 
Substantial polymorphic patterns were revealed only when isolates of different species were 
compared. There were no such observed for L. infantum and L. chagasi, for L. mexicana and 
L. amazonensis and for L. guyanensis and L. panamensis, respectively. L. major, L. tropica 
and the members of the L. mexicana, L. brasiliensis and L. donovani complexes were clearly 
differentiated from each other by their varying amplification product patterns. Within those 
 58 
complexes similar PCR profiles were found and several common DNA fragments were 
amplified. Small differences resemble rather those strains belonging to the same species than 
different species. 
Overall the unidentified isolates that were processed through fingerprinting with single 
arbitrary primers gave the following results; Isolates S(d)1-S(d)21 were clearly identified as 
L. infantum according to all single primers. Data obtained with the primer M13 suggest that 
isolates S(h)22-S(h)25 belonged to L. aethiopica and L. tropica species (Figure 8). Using the  
primer T3B they were more similar to L. aethiopica, while with the (GACA) 4 S(h)22, S(h)24 
and S(h)25 were similar to L. tropica and S(h)23 to L. aethiopica. S(h)26 and S(h)28 had 
similar patterns to L. brasiliensis complex when they were primed with the primers M13 
(Figure 8) and T3B, while when primed with (GACA)4 they were more similar to L. 
guyanensis which is part of the complex. S(h)27 was identified to be L. donovani according to 
all primers, S(h)29 L. chagasi and S(h)30 L. brasiliensis. 
 
 
4.5 Fingerprinting using the primer pair L1119 
 
Trying to optimize the PCR reactions with the codominant markers (see §3.2.2) different to 
expectations, the primer pair L1119 did not produce a single band. However, it produced 
interesting fingerprinting patterns that after optimisation gave very similar results with the 
other four single primers (Figure 7).  
 
All reference strains, isolates S(d)1-S(d)21 and S(h)22-S(h)30 were processed through it and 
each isolate yielded 11 to 22 bands ranging between 1800 bp and 300 bp. The results from the 
L1119 were processed through the same computer assisted analysis like the other primers and 
the evolutionary tree 7 (Dendrogramme 7) was constructed. 
 
The complexes L. donovani, L. mexicana and L. brasiliensis are distinct while L. aethiopica, 
L. tropica and L. major are relatively standing on their own. Within the L. brasiliensis 
complex L. guyanensis and L. panamensis grouped very close together and the Viannia group 
is very well statistically supported. The Greek L. infantum isolates are found in three different 
subgroups. In general the isolates of the L. infantum complex are distributed homogeneously 
within the complex without comprising any groups that indicate major geographical 
separations. That may be due to the fact that in this case the primer pair that was used, was 
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randomly chosen. It may be amplifing on chromosomal DNA i.e the multiple bands, indicate 
a repeated sequence of different size in the chromosomal genome.  
 
 
4.6 Analysis of codominant anonymous PCR markers 
 
The results from the PCR-SSCP with ITS1 amplifying primer set and the codominant markers 
are summarised in Table 7. The isolates that were processed with the codominant markers 
were all L.infantum isolates, including the Greek canine isolates S1-S21, the DON-01 and 
DON-04, the L.chagasi reference strain and the LS29 that was identified as L.chagasi (Table 
2). 
 
The underlying principle of the SSCP method is that the electrophoretic mobility of a single-
stranded DNA molecule in a non-denaturing gel is dependent on its size and structure (= 
conformation). Since conformations are highly dependent on primary sequence, each ssDNA 
molecule will adopt a tertiary conformation, based on nucleotide sequence, which results in 
differences in relative mobility. Examples of that can be seen in Figures 12 compared to 
figures 10 and 11. Figure 10 shows that the pattern of the given isolates is identical for all 
given isolates when the PCR product of the primer pair L0110 is subjected to SSCP. This 
means that there is no single nucleotide mutation in the sequence of this amplified product for 
the given isolates. The same result was obtained when the primer pair L0720 was used for the 
isolates S(d)1-S(d)11 (figure 11). Nevertheless the results are different when the primer pair 
L1112 was used (figure 12). Differences are observed in the reference strains 
MHOM/CN/78/D2, MHOM/FR/80/189, MHOM/IL/89/LRC-L571 and the rest of the 
subjected isolates mainly because of single nucleotide mutations. 
 
To summarise the results of this experiment the Table 7 was prepared. Each column 
represents a primer pair and each line a tested isolate. Different signs stand for each primer for 
each different pattern. 
 
Thus the SSCP assay of the ITS1, L01012, L0720, L0510, L0114, L0413 and L0110 
amplicons yielded no variation, while 5 different groups were observed when the L1112 
primer was used. The chinese isolate INF-04 gave a unique pattern, the two french isolates 
INF-05 and INF-06 gave another, the spanish INF-19 a third, the CHA-01 and S(h)29 a 
 60 
fourth. In all other cases a fifth common pattern was obtained. It is important to note that 
L1112 is the only primer which seperates L. chagasi (CHA-01) and the S(h)29 from others of 
the L. donovani complex. S(h)29 was identified as L. chagasi also with the fingerprinting with 
the single arbitrary primers. It is intersting to see that the two L. donovani strains that were 
used (DON-01 and DON-04) do not yield any different patterns. When the primer pair L1012 
was employed in PCR with L. major DNA, a band of about 600 bp was produced while the 
product of the L. infantum and L. chagasi was only 200 bp in size (not shown). 
 
Table 7: Results of the PCR-SSCP of anonymous markers. In each row, one symbol has been 
chosen representing the pattern yielded from the specific primer. When a different symbol 
appears in the given row, is because a different pattern is yielded from the specific primer 
pair, when it amplifies in the specific isolate.  
 
Sample No ITS1 L1012 L0720 L0510 L0114 L1112 L0413 L0110 
S(d)1 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)2 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)3 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)4 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)5 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)6 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)7 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)8 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)9 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)10 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)11 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)12 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)13 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)14 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)15 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)16 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)17 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)18 • ∇ ∗ ◊   ♠ ℵ ° 
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S(d)19 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)20 • ∇ ∗ ◊   ♠ ℵ ° 
S(d)21 • ∇ ∗ ◊   ♠ ℵ ° 
INF-01 • ∇ ∗ ◊   ♠ ℵ ° 
INF-03 • ∇ ∗ ◊   ♠ ℵ ° 
INF-04 • ∇ ∗ ◊   ∠ ℵ ° 
INF-05 • ∇ ∗ ◊   ∧ ℵ ° 
INF-06 • ∇ ∗ ◊   ∧ ℵ ° 
INF-07 • ∇ ∗ ◊   ♠ ℵ ° 
INF-09 • ∇ ∗ ◊   ♠ ℵ ° 
INF-10 • ∇ ∗ ◊   ♠ ℵ ° 
INF-11 • ∇ ∗ ◊   ♠ ℵ ° 
INF-12 • ∇ ∗ ◊   ♠ ℵ ° 
INF-13 • ∇ ∗ ◊   ♠ ℵ ° 
INF-14 • ∇ ∗ ◊   ♠ ℵ ° 
INF-15 • ∇ ∗ ◊   ♠ ℵ ° 
INF-16 • ∇ ∗ ◊   ♠ ℵ ° 
INF-17 • ∇ ∗ ◊   ♠ ℵ ° 
INF-18 • ∇ ∗ ◊   ♠ ℵ ° 
INF-19 • ∇ ∗ ◊   ℑ ℵ ° 
CHA-01 • ∇ ∗ ◊   ∅ ℵ ° 
S(h)29 • ∇ ∗ ◊   ∅ ℵ ° 
DON-01 • ∇ ∗ ◊   ♠ ℵ ° 
DON-04 • ∇ ∗ ◊   ♠ ℵ ° 
S(h)27 • ∇ ∗ ◊   ♠ ℵ ° 
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INF-19
S(d)5
PAN
INF-16
DON-01
S(h)25
S(d)12
INF-11
S(h)27
INF-05
TRO-02
INF-01
INF-12
S(h)28
S(d)11
DON-04
S(d)13
TRO-22
S(d)3
INF-15
S(d)9
S(d)10
S(d)4
S(d)7
S(d)6
S(d)16
S(d)1
S(d)17
S(d)2
S(d)19
S(d)8
S(d)20
S(d)14
S(d)15
S(d)18
S(d)21
CHA-01
S(h)29
INF-03
INF-04
INF-17
INF-18
INF-09
INF-10
INF-13
INF-14
AETH
S(h)23
S(h)22
S(h)24
MAJ-03
MAJ-01
AMA
MEX
BRA
S(h)30
GUA
S(h)26
100
99
95
61
63
92
99
52
50
92
66
57
72
83
100
66
 
 
IND 
Geographical  
origin 
E 
E 
RC 
TN 
TR 
IL 
IL 
IL 
PT 
TR 
IL 
FR 
IL 
IL 
IL 
ETH 
IR 
IR 
ETH 
SU 
TR 
ETH 
SU 
RUS 
BH 
? 
CR 
BR 
BR 
BR 
BR 
BR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
BR 
MEX
EAK
SU 
Dendrogramme 1: Evolutionary tree produced by the results of the
fingerprinting PCR with the single arbitrary primer (GACA) 4. 
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 CHA-01
S(d)4
INF-01
INF-03
INF-08
GUA-01
S(d)8
S(d)9
S(d)6
S7
S(d)1
S(d)2
S(d)3
S(d)5
S(d)18
S(d)19
S(d)20
S(d)21
S(d)12
S(d)13
S(d)10
S(d)11
S(d)14
S(d)15
S(d)16
S(d)17
INF-04
INF-07
INF-05
INF-06
DON-01
DON-04
TRO-02
TRO-22
MJ-01
MJ-03
AMA-01
MEX-03
BRA-01
PAN-01
55
51
91
96
61
65
55
100
57
85
100
 
Geographical  
origin 
TN 
E 
RC 
IL 
TR 
F 
F 
BR 
IND 
EAK 
SU 
TR 
RUS 
SU 
BH 
? 
BR 
BR 
CR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
Dendrogramme 2: Evolutionary tree produced by the results of the fingerprinting
PCR with the single arbitrary primer (GTG) 5. 
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 S(d)1
INF-07
S(h)28
INF-19
INF-14
INF-13
S(h)26
INF-18
INF-08
S(d)10
S(d)9
S(h)23
INF-06
S8
S(d)15
S(d)7
S(d)17
INF-15
S(h)27
S(h)24
AETH-03
S(d)11
S(d)14
S(d)6
S(d)18
S(d)12
S(d)21
S(d)13
S(d)16
S(d)19
S(d)20
S(d)4
S(d)5
S(d)2
S(d)3
INF-03
INF-04
INF-01
INF-05
INF-10
INF-11
INF-09
INF-12
INF-16
INF-17
CHA-01
S(h)29
DON-01
DON-04
AMA-01
MEX-03
Bra-01
S(h)30
GUA-01
PAN-01
S(h)22
S(h)25
TRO-02
TRO-22
MJ-01
MJ-03
94
91
63
65
50
52
63
100
72
95
100
64
96
52
81
 
 
                
Geogr phical  a
origin 
TR 
TR 
P 
IL 
E 
IL 
IL 
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IL 
IL 
BR 
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SU 
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EAK 
BR 
BH 
? 
BR 
BR 
BR 
BR 
CR 
IR 
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ETH 
IR 
SU 
TR 
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SU 
E 
RC 
TR 
F 
TN 
F 
IL 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
Dendrogramme 3: Evolutionary tree produced by the results of the
fingerprinting PCR with the single arbitrary primer M13.  
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S(h)26
S(h)28
PAN-01
DON-01
INF-14
S(d)21
INF-12
INF-19
DON-04
GUA-01
S(d)9
S(d)10
S(d)7
S(d)8
S(d)3
S(d)4
S(d)5
S(d)6
S(d)19
S(d)20
S(d)1
S(d)2
S(d)13
S(d)14
S(d)11
S(d)12
S(d)15
S(d)16
S(d)17
S(d)18
INF-04
INF-05
INF-16
INF-18
INF-01
INF-03
INF-15
INF-17
INF-11
INF-13
INF-09
INF-10
CHA-01
S(h)29
MJ-01
MJ-03
TRO-02
TRO-22
AETH
S(h)23
S(h)25
S(h)27
S(h)22
S(h)24
AMA-01
MEX-03
BRA-01
S(h)30
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55
55
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55
54
50
91
51
71
100
 primer T3B. 
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IR 
ETH 
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Dendrogramme 4: Evolutionary tree produced by the results of the
fingerprinting PCR with the single arbitrary
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S(d)1
INF-10
INF-19
S(d)12
S(d)8
INF-14
S(d)2
INF-18
INF-12
INF-05
S(d)3
PAN-01
INF-09
S(d)10
INF-04
INF-16
S(d)13
S(h)26
S(h)27
AETH-03
S(d)16
S(d)17
S(d)9
S(d)11
S(d)4
S(d)5
S(d)6
S(d)7
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80
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100
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Dendrogramme 5: Evolutionary tree produced by the results of the
fingerprinting PCR with the single arbitrary primers M13, (GACA) 4 and
T3B. 
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 S(d)1
S(d)5
INF-19
S(d)8
S(d)12
S(d)2
INF-14
S(d)3
INF-18
INF-05
INF-16
S(d)10
S(d)13
S(d)4
INF-04
INF-12
CHA-01
S(d)16
S(d)17
S(d)9
S(d)11
S(d)6
S(d)7
S(d)14
S(d)15
S(d)19
S(d)20
S(d)18
S(d)21
INF-01
INF-03
INF-10
INF-11
INF-09
INF-13
INF-15
INF-17
DON-01
DON-04
65
57
100
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57
100
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89
54
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59
58
61
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Dendrogramme 6: Evolutionary tree produced for the L.donovani complex with
the results of the fingerprinting PCRs with the single arbitrary primers M13, T3B
and (GACA) 4. 
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AETH-03
S11
INF-10
INF-04
INF-13
S15
INF-16
S(d)21
DON-06
S(d)2
DON-08
INF-11
INF-09
CHA-01
S(d)3
S(d)13
BRA-01
S(d)18
INF-12
INF-14
INF-01
INF-15
S(d)14
S(d)16
S(d)12
S(d)17
S(d)19
S(d)20
INF-05
INF-17
INF-18
INF-19
INF-03
DON-10
DON-02
DON-04
S(d)5
S(d)6
S(d)9
S(d)10
S(d)4
S(d)7
S(d)1
S(d)8
MJ-03
TRO-22
MEX-03
AMA-01
GUA-01
PAN-01
46
88
59
79
45
66
94
 
Geog phical  ra
origin 
TR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
GR 
ETH 
SU 
TR 
? 
BH 
BR 
BR 
CR 
GR 
GR 
GR 
IL 
GR 
GR 
GR 
GR 
IL 
P 
F 
IL 
IL 
E 
RC 
E 
IND 
BR 
SU 
SU 
EAK 
EAK 
IL 
IL 
TR 
TN 
IL 
GR 
GR 
GR 
Dendrogramme 7: Evolutionary tree produced by the results of the
fingerprinting PCR with the primers pair L1119. 
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The country of origin contained in the brackets next to each isolate, in the right side of each 
dendrogramme is signed according to the internationaly used abbreviations as following: 
 
BH: Belise 
BR: Brasil 
CR: Costa Rica 
E: Spain 
EAk: Kenya 
ETH: Ethiopia 
F: France 
GR: Greece 
IL: Israel 
IND: India 
IR: Iran 
MEX: Mexico 
P : Portugal 
RC : China 
RUS: Russia 
TN: Tunesia 
TR: Turkey 
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 Figure 2: RFLP analysis patterns of the ITS region after digestion
with HaeIII. Lanes 1 and 22: molecular size markers in bp; lanes
2-21: Leishmania isolates S(d)1-S(d)20 from dogs from Northern
Greece. 
 
 
 
 
 1    2   3  4   5   6   7   8   9   10 11 12 13 14 15 16 17 18 19 20 21 22  
 
 
 492 
369 
246  
123 
 
 
 
Figure 3: RFLP analysis of the ITS region after digestion with CfoI.
Lanes 1 and 22: molecular size markers in bp; lanes 2-21:
Leishmania isolates S(d)1-S(d)20 from dogs. 
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Figure 4: PCR fingerprinting profile obtained with the T3B primer. Lanes 1, 11
and 18: molecular size markers in kb; lanes 2-10 and 12: Leishmania isolates from
dogs; lane 13: L.donovani (MHOM/IN/89/DD8); lane 14: L.infantum
(MHOM/TN/80/IPT1); lane 15: L.major (MHOM/SU/73/5ASKH); lane 16:
L.tropica (MHOM/SU/79/LRC-L39); lane 17: control sample without DNA. 
 
 
 
 
1      2     3     4      5      6      7     8     9      10    11    12    13    14   15    16    17   18 
 
 
3.0 
 
2.0 
 1.6 
 
1.0 
 
 0.5 
 
Figure 5: PCR fingerprinting profile obtained with the (GACA)4 primer. Lanes 1, 10
and 18: molecular size markers in kb; lane 2: control sample without DNA; lane 3:
L.major (MHOM/SU/73/5ASKH); lane 4: L. infantum (MHOM/TN/80/IPT1); lane 5:
L.donovani (MHOM/IN/80/DD8); lane 6: L.tropica (MHOM/SU/79/LRC_L39);
lanes 7-9 and 11-17: Leishmania isolates from dogs. 
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Figure 6: PCR fingerprinting profile obtained with the M13 core sequence primer. Lanes
1,11,22,23,30 and 37: molecular size markers in kb; lanes 2-10, 12-21 and 24: Leishmania
isolates from dogs; lane 25: control sample without DNA; lane 26: L.donovani
(MHOM/IN/80/DD8); lane 27: L.tropica (MHOM/SU/79/LRC-L39),; lane 28: L.major
(MHOM/SU/73/5ASKH); lanes 29 and 31-36: L.infantum (MHOM/TN/80/IPT1,
MHOM/FR/62/LRC-L47,MHOM/ES/87/Lombardi,MHOM/CN/78/D2,MHOM/FR/80/189, 
MCAN/IL/96/LRC-L709, MHOM/TR/96/EP16). 
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Figure 7: PCR fingerprinting profiles with the (GTG)5 primer. Lanes 1,11,22,23,30 and 37:
molecular size markers in kb; lanes 2-10, 12-21 and 24: Leishmania isolates from dogs;
lane 25: control sample without DNA; lane 26: L.donovani (MHOM/IN/80/DD8); lane 27:
L.tropica (MHOM/SU/79/LRC-L39); lane 28: L.major (MHOM/SU/73/5ASKH); lanes 29
and 31-36: L.infantum (MHOM/TN/80/IPT1, MHOM/FR/62/LRC-
L47,MHOM/ES/87/Lombardi,MHOM/CN/78/D2,MHOM/FR/80/189, MCAN/IL/96/LRC-
L709, MHOM/TR/96/EP16).  
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Figure 8: PCR fingerprinting profile with the L1119 primer pair. Lanes 1, 8 and
14: molecular size markers in kb; lane 2: L.infantum (MHOM/TN/80/IPT1); lane
3: L.donovani (MHOM/KE/85/NLB323); lane 4: L. chagashi
(MHOM/BR/74/PP75; lane 5: L.major ((MHOM/SD/90/Sudan3); lane 6:
L.tropica (MHOM/TR/95/URFA7); lane 7: L.aethiopica
(MHOM/ET/94/Abauye); lane 9: L.mexicana (patients isolate); lane 10:
L.amazonensis (MHOM/BZ/73/M2269); lane 11: L.brasiliensis
(MHOM/BR/75/M2903); lane 12: L.guyianensis (MHOM/BR/75/M4147; lane
13: L.panamensis (MHOM/CR/87/NEL3.  
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 Figure 9: PCR fingerprinting profile with the M13 core sequence. Lanes 1, 8, 16 and
20: molecular size markers in kb; lane 2: L.infantum (MHOM/TN/80/IPT1; Lane 3:
L.donovani (MHOM/KE/85/NL/B323); Lane 4: L.chagasi (MHOM/BR/74/PP75);
Lane 5: L.major (MHOM/SU/73/5ASKH); lane 6: L.tropica (MHOM/SU/74/SAF-
K27); lane 7: L.aethiopica (MHOM/ET/94/Abauye; Lane 9: S(h)22; Lane 10:
S(h)23; Lane 11: S(h)24; Lane 12: S(h)25; Lane 13: S(h)26; Lane 14: S(h)27; Lane
15: S(h)28; Lane 17: L. brasiliensis (MHOM/BR/75/M2903); Lane 18: L.guyianensis
(MHOM/BR/75/M4147); Lane 19: L.panamensis (MHOM/CR/87/NEL3).  
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Figure 10: SSCP pattern of the PCR product of the primer pair L0110. Lanes
1-18 contain amplicons of canine isolates S(d)1-S(d)18 that were identified to
belong in the L.infantum by PCR fingerprinting with arbitrary primers. 
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 Figure 11: SSCP pattern of the PCR product of the primer pair L0720.
Lanes 1-11 contain amplicons of canine isolates S(d)1-S(d)11 that were
identified to belong in the L.infantum by PCR fingerprinting with arbitrary
primers. 
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Figure 12: SSCP pattern of the PCR product of the primer pair L1112. Lanes 1-20,
S(d)2-S(d)21; Lane21, MHOM/TN/80/IPT1; Lane  22, MHOM/ES/87/Lombardi;
Lane 23, MHOM/CN/78/D2; Lane 24, MHOM/FR/80/189; Lane 25,
MHOM/IL/89/LRC-L571. All lanes contain amplicons of canine isolates that were
identified to belong in the L.infantum by PCR fingerprinting with arbitrary primers. 
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5. DISCUSSION 
The main aim of this work has been the evaluation of PCR methods for detection, species 
identification and determination of genetic variation in L. infantum. In that frame a greater scale 
of Leishmania isolates from patients, humans and dogs were processed through for detection of 
the parasite, detection of the species and further to search genetic variation in L. infantum. The 
combination of ITS-RFLP, fingerprinting with single arbitrary primers and PCR-SSCP with 
codominant markers, produced results that contributed to all directions. In particular the 
experiments aimed to characterise isolates from Greece and the greater Mediterranean area. 
Concerning identification of leishmanial parasites in Greece very little is known although the 
disease is endemic there. There is only one recent paper by Aransay et al. (2000), applying a 
semi-nested PCR, based on the minicircle sequence of L. donovani described by Smyth et al. 
1992. By comparison of the sequence of the PCR products with Leishmania sequences of the 
Genomic data bank in the internet, they concluded that the amplification products most 
probably belonged to L. infantum and L. donovani. Earlier works using isoenzyme analysis 
revealed the existance of L. infantum (MON-1) in both human and canine patients, and L. 
tropica (MON-57 and MON-114) in humans (Frank et al., 1993). L. infantum was isolated 
from Phlebotomus neglectus on the island of Corfu (Léger et al., 1988). 
The PCR technique applied in this study to detect the parasites was originally developed by 
Meredith et al., (1993). Osman used it in greater scale epidemiological studies, for diagnosis 
(Osman et al., 1997; 1997b; 1998) and management (Osman et al., 1997; 1997b; 1998; 1998b; 
1998c) of the disease. They amplified a 560 bp variable fragment of the ssu rRNA gene. 
The diagnostic PCR (§3.1) in our hands proved to be reliable test. It gave a positive result to all 
the isolates that had been previously identified as L. infantum and all the L. infantum 
characterised strains from Table 2 (§ 3.1). Also all the 24 samples from dogs (BS1-BS24) 
diagnosed with leishmaniasis in Germany after having travelled in South Europe (21 bone 
marrow, 1 lymph node and 2 blood) (§ 3.1), were positive when processed through this PCR. In 
the latter cases it corresponds to 100 % with previous diagnosis by axenic culture inoculation 
(Steuber, personal communication).  
The assay used in the present study seems a very promishing Leishmania detection method and 
it should maybe considered becoming part of the officially by the WHO recommented 
diagnostic routine methods for the L. donovani complex. 
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Kinetoplastid specific sequences were previously used in hybridization assays but the results 
were not as good as expected because of the intrataxon variations in restriction patterns. 
Hybridization efficiency and sequence of the minicircle made kDNA an unlikely candidate for 
a simple classification of Leishmania (Rodgers et al., 1986; van Eys et al., 1989). The ssu 
rRNA gene was originaly used by van Eys et al., 1992. The DNA as well as the RNA of the ssu 
rRNA could be used a target for a PCR assay. The nuclear DNA contains about 160 copies of 
the ssu rRNA gene and the cytoplasm contains more than 104 ssu rRNA molecules (Leon et al., 
1978).  
In the dendrogrammes produced from the results of the fingerprinting with single arbitrary 
primers isolates of the same species do cluster together. The patients' isolates (Results § 4.3, 
Table 6) can be correlated to an isolate of the reference strains when the ITS product is digested 
with either restriction enzymes HaeIII or CfoI (Materials and Methods § 3.1, Table 2). Based 
on these results the same isolates were further prosessed to the fingerprinting with the single 
arbitrary primers.  
The ITS region seems to be very concerved in all representatives of L. infantum. Nineteen (19) 
well characterised L. infantum strains (INF-01 to INF-19), the isolate CHA-01, 21 isolates from 
dogs (S1-S21) and 2 human isolates that were processed through the ITS-RFLP. They were 
identical not only with the L. infantum but also with the L. donovani and L. chagasi reference 
strains. Of those 42 were were further characterised via fingerprinting with single arbitrary 
primers as L. infantum and one as L. chagasi. Corresponding results were obtained for L. 
donovani isolates with ITS-RFLP by Schönian (personal  communication), they observed some 
variation which we could not find in our isolates. The heterogeneity reported by El Tai et al. 
(2000), was due to point mutations that did not affect the digestion sites of the sequence. So 
overall it seems that there were almost no intra-complex, or intra-species variations, in the L. 
donovani complex (including L. infantum, L. donovani and L. chagasi), when refering to the 
ITS region. This is not the case for the New World Leishmania species (Cupollilo et al., 1995), 
or the L. aethiopica and L. tropica (Schönian et al., 2000; Schönian et al., personal 
communication). 
When the PCR-fingerprinting with the single arbitrary primers was applied, the polymorphisms 
of different species and strains of Leishmania and merely Leishmania infantum were assesed. It 
has been suggested that polymorphic DNA markers amplified with single non specific primers 
may be very accurate indicators of genetic distances because this PCR randomly samples 
sequence polymorphisms distributed in the genome (Welsh et al., 1992). In most cases this 
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method detects DNA polymorphisms that are generated from primer sites in one sample beeing 
exactly complementary to the primer, whereas the priming site of another sample is not an 
exact complement to the primer.  
Polymorphisms may be due to single base changes in genomic DNA, deletions and insertions 
that change the size of the DNA fragment, deletions of a priming site, or insertions that render 
the priming sites too distant to support amplification. Since amplification perameters influence 
strongly the resulting patterns, it is necessary that the protocols used are well optimised, 
especially concerning the primer/template ratios, annealing temperature and Mg2+ ions 
concentration.  
Our data indicate that relationships of Leishmania species, as compared the PCR profiles, were 
consistent with previous taxonomic studies (Beverley et al., 1987; Makedo et al., 1992; 
Schönian et al., 1996). Dinstinctive and reproducible sets of amplified DNA fragments were 
obtained for all Leishmania isolates tested. The PCR profiles within the main Leishmania 
complexes (L. donovani, L. mexicana, and L. brasiliensis) are clustering together but they are 
still distinct with one another. The unrooted distance tree based on the combined data matrices 
(Dendrogramme 5) that was obtained with each primer reveal that all Leishmania species tested 
clustered into two major group of Leishmania species: the subgenera Viannia (L.braziliensis 
complex) and Leishmania. This branching is well supported by bootstrapping. Within the 
human isolates S(h)22-S(h)30, isolates S22-S25 belonged to L. aethiopica and L. tropica when 
using the M13 primer, to L. aethiopica in case of the T3B primer, while when employing the 
(GACA) 4 primer, S(h)22, S(h)24 and S(h)25 belong to L. tropica and S(h)23 to L. aethiopica. 
In the ITS-RFLP S(h)22, S(h)24 and S(h)25 seemed to belong to L. tropica and S(h)23 to L. 
aethiopica whereas in the Dendrogramme 5 of the combined data they cluster together in a 
greater cluster that is shaped by the clusters of L. tropica and L. aethiopica. However it is 
possible that those isolates derive from a mixed infection from both species. They are to a great 
part co-endemic. That is also possible in the case of S(h)26 and S(h)28, which primed with M13 
and T3B, cluster with L.brasiliensis and with (GACA) 4 with L.guyanansis. 
The L. infantum isolates, INF-01 to INF-19 and S(d)1-S(d)21, a total stock of 40 isolates, 9 
human and 31 canine ones, was easily identified as L. infantum with each of the 4 single 
primers. As obvious from dendrogrammes 1, 2, 3 and 4 grouping and subdivisions of the 
isolates were correlated merely to the geographical origin. Combined data for the L. donovani 
complex only (L. infantum, L. donovani, and L. chagasi), were obtained when the isolates were 
primed with M13, T3B and (GACA) 4 (Dendrogramme 6). Groupings are supported very well 
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from bootstrap values and again the subgroupings of each isolate correlates to the geographical 
distribution  
An interesting isolate is S(h)29. It derives from a patient who within a year travelled to Spain, 
Mexico and Brasil, countries where both American and Old World VL are endemic. This 
geographic origin is not of any help in this case. When it was processed through the ITS-RFLP 
it gave patterns of the L. donovani complex. When it was afterwards processed through the 
fingerprinting, it clustered with the CHA-01 when primed with M13, T3B and (GACA) 4 with 
very high bootstrap values in all three cases. Nevertheless it stands very close to the other  two 
species within the L. donovani complex. However, the codominant marker L1112 was a great 
help because it led to a different set of pattern for the isolates CHA-01 and the S(h)29. This 
result supports the opinion that L. chagasi, the causative agent for American VL, has been 
imported by humans from the Old to the New World (Momen et al., 1993). 
The RFLP analysis of the ITS region after digestion with the restriction enzymes HaeIII and 
CfoI enabled to distinguish the parasites at complexes level. It is a method that in the future can 
be also used in clinical samples (biological material as blood, bone marrow etc. infected with 
the parasite) since the primers are specific for the Leishmania genus.  
The fingerprinting with the arbitrary primers distinguished and identified the isolates at species 
level even within the complex. Concerning species identification, the results of each primer are 
confirmed by the results of the others. In the fingerprinting with single arbitrary primers pure 
cultured parasites are needed because the primers are not species specific . 
Concerning the primer pair L1119, it produces results that agree with these of the four 
fingerprinting systems with the single arbitrary primers eventhough the bootstrap values are 
low. The different species are clustering separate while species of the same complex are 
shaping greater clusters. Concerning L. infantum, predominantly the Greek canine isolates 
group together. In conclusion there seems to be very little variation within the L. infantum, 
group. 
The codominant markers are able to detect both alleles in a diploid. Those used in this study 
were designed for epidemiological and population genetic studies in L. donovani (L. donovani, 
L. infantum and L. chagasi) complex (Schönian, personal communication). Seven anonymous 
markers were applied to the INF-01 to INF-19, CHA-01, S(d)1-S(d)21 and S(h)29. In those 
samples only the marker L1112 revealed polymorphisms. Two French human isolates (INF-05 
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and INF-06) give a common pattern, a Chinese human (INF-04) a second, a Spanish canine 
(INF-19) a third and interestingly the CHA-01 and the S(h)29 another fourth one. The latter 
two are interesting because up to now differences between L. infantum and L. chagasi were 
rarely found and the one is mostly considered to be a geographical deportation of the other 
(Burns et al., 1993; Carreira et al., 1995). The ability to detect both alleles in a diploid 
organism such as Leishmania is desirable for population studies. Information about the heredity 
mode of genes, whether dominant tendency of expression or not in case of heterogygous 
populations and heterogygoty itself in case of recombinal mode of propagation of the parasite 
are of major importance. Furthermore, those markers can be possibly amplified directly from 
clinical samples without cultivation of the parasites, while PCR fingerprinting methods need 
pure parasite material.  
Is is interesting to note that in the case of combined data used for Dendrogramme 5, four 
isolates INF-05, INF-04, INF-01 and INF-03, coming from France, China, Tunisia and Spain, 
respectively are clustering together in the same subgroup with a bootstrap value of 100 %. This 
is a good indication that the variation within L. infantum, in general, is not very high, no matter 
the geographical region most probably even the host of origin of the isolate and fingerprinting 
allows differenciation due to the geographical origin. At the fingerprinting with the single 
arbitrary primer T3B (Dendrogramme 2) all the Greek canine isolates have identical patterns. 
The same is true for the isolates INF-15 and INF-17 both canine from Israel. Identical patterns 
gave also INF-09 INF-10 INF-13, INF-14, and INF-11 (4 canine and 1 human respectively), 
one isolate from Portugal (INF-09), two from Turkey (INF-09, INF-10) and two from Israel 
(INF-13, INF-14), i.e. parasites from distant areas and different hosts.At the fingerprinting with 
the primer (GTG) 5 the 20 of the 21 Greek canine L. infantum isolates gave once again identical 
patterns. The fingerprintings of the L. infantum isolates with the M13 and (GACA) 4 primers 
gave few sporadic identical patterns between isolates. Differences due to the geographical 
origin are supported even better in the combined data Dendrogramme 6 for the L. donovani 
complex. The denrogramme gives distinct clades to each strain, showing that each strain is 
formated by a unique group of molecular characteristics. The bootstrap values are also very 
high in all clades of the tree. 
Independent assortment or recombination by crossing over during meiosis can scramble the 
parental alleles to give non parental combinations. The farther apart two genes are on a 
chromosome, the more likely recombination by crossing over between them will be. That's 
how theoritically recombination might simplisticaly take place. In 1998 Britto et al., showed 
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that the haploid genome of Old World Leishmania contains 36 chromosomes, while the 
number is different in the Viannia and the New World Leishmania subgenera. Along with that 
there are studies that suggest that Leishmania chromosomes are largely diploid with some 
aneuploid chromosomes (Andrews et al., 1988). On the other hand if reproduction was strictly 
clonal the genotype would be replicated as a unit and independently propagating clonal 
lineages could evolve highly divergent karyotypes. Since the absolute ploidity and sexuality 
of Leishmania are uncertain, the importance of chromosomal recombination in the evolution 
of Leishmania also remains an area of speculation. Of course there is always the possibility 
that the different developmental stages are accompanied by chromosomale rearrangements 
eventhough there are no such reports yet. 
 
The very limited degree of genetic variation among the strains of L. infantum from Greece in 
this study is consistent within the results of all the methods that were used (ITS-RFLP, 
fingerprinting with single arbitrary primers, PCR-SSCP). In a recent work from Spain (Jimenez 
et al., 1995) certain zymodemes of L. infantum were found exclusively in 
immunnocompromised patients and were absent from the typical cases of canine VL and CL. It 
was suggested that there is either an anthroponotic pattern of leishmaniasis where e.g. drug 
users act as the reservoirs for the new zymodemes, or that the cellular immune system could 
select virulent from non-virulent zymodems in immunocompetent VL patients. In a follow up 
study (Jimenez et al., 1997) the parasite population isolated from AIDS patients was of the 
same dominant “clonal” genotype (MON1). Thus once again strong linkage disequilibrium, 
over-representation of genotypes and overall lack of genotype diversity was shown. 
Despite the broad enzymatic heterogeneity (WHO, 1990) that has been demonstrated from 
other workers among strains of L.infantum a clonal mode of propagation has been proposed 
for this species (Tibayrenc et al., 1990; Jimenez et al., 1997; Banuls et al., 1999). This 
hypothesis was based on (a) the existence of over-represented, geographically widely 
distributed genotype (zymodeme MON-1), and (b) the strong linkage disequilibrium in this 
species. However, occasional genetic exchanges are not excluded in predominantly clonal 
populations. 
In the present study the hypothesis of clonality within L. infantum is supported from the 
combination of the ITS-RFLP results with the results of the fingerprinting with the single 
arbitrary primers and the PCR-SSCP. Particularly the ITS-RFLP fails to show variation within 
the L. donovani complex, while there is some heterogeneity demonstrated with the other two 
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methods. In principle this implies a tendency of conservation within the L. donovani complex 
that which suggests a more clonal development within L. infantum. It might be important in the 
future, to compare and combine species phylogenies obtained from single-primed PCR profiles 
with those derived from DNA sequencing data.  
Clonality may be of importance not only for diagnosis of the disease but also for therapy, 
control methods, monitoring and management of the applied measures. Since we suggest that 
the L. infantum is in the majority clonal, it is easier to plan, apply and monitor strategic 
control methods, especially in an area like the Medditeranean. The problems of arising 
resistance development due to multiple recombination and mutation, after long time of drug 
therapy, are at least potentially reduced. All those factors together, are assembling a good 
potential when epidemiology some time will be used for systematic control of the infantile 
leishmaniasis. 
 
When we applied the ITS-RFLP and the fingerprinting with single arbitrary primers we had 
two main goals: first to discrinimate amongst often closely related species and second to 
establish the quantitative degree of evolutionary relationship. The use of ITS-RFLP is an 
excellent tool to aquire an original direction and to discriminate the complex an isolate 
belongs to. The further exact identification of the species is resulting by the use of the PCR 
assay with the single arbitrary primers. The results can be confirmed by the parallel use of 
more than one single arbitrary primers. The combination of the two methods is a great 
weapon in the diagnostic quiver of leishmaniasis. Both are not complicated and after 
establishing them in the laboratory routine one can easily process a great number of isolates 
through. It would be worth while to apply them in an even greater scale using more isolates 
and comparing patterns of different species in a greater scale. It would be definitely a 
fascinating exploration of the variation also in other Leishmania species. 
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6. SUMMARY 
The aim of this study was the evaluation of PCR methods for detection, species identification 
and determination of genetic variation in L.infantum. 
 
For this reason a total of 36 well-characterised Leishmania strains, 21 canine isolates from 
Northern Greece, 9 human Leishmania isolates from various locations and 24 clinical samples 
from German dogs that had travelled to South Europe, suffering from clinical leishmaniasis, 
were used. 
 
First the internally transcribed spacer (ITS) was amplified and the amplification products 
were digested with the restriction enzymes HaeIII and CfoI. The 36 well-characterised 
Leishmania strains, the 21 canine and 9 human isolates were tested. This process allowed to 
characterise the isolates to the complex level and some to the species level (L. aethiopica, L. 
tropica). The patterns acquired for the L. donovani complex (L. infantum, L. donovani, L. 
chagasi) were identical. 
 
The same isolates were subsequently tested with fingerprinting with single arbitrary primers. 
The primers used derived from the core sequence of the phage M13, intergenic tRNA genes' 
spacers (T3B) and the repeat sequences (GTG)5 and (GACA)4. The 21 canine isolates were all 
identified as L. infantum three (3) of the human isolates corresponding with  L. tropica, one 
(1) with L. aethiopica, one (1) with L. donovani, one (1) with L. chagasi, one (1) with L. 
brasiliensis and two (2) with L. guayanensis. All produced polymorphic patterns which were 
grouping depending on the species they belonged to, next to the relevant well-characterised 
strains of the same species. Within the L. infantum group the subgroupings formed were 
mainly related to the geographical origin of the strains. 
 
A polymerase chain reaction-single strand conformation analysis (PCR-SSCP) using a set of 8 
codominant primer pair markers was employed to test a total of 42 L. donovani complex 
strains (38 L. infantum, 2 L. chagasi and 2 L. donovani). Only one primer pair marker gave 
some variation patterns at the SSCP for the L. chagasi reference strain and a human isolate of 
debatable origin. Both had the same SSCP-pattern as well as the same fingerprinting pattern 
with single arbitrary primers. 
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A simple PCR detection system for L. donovani which amplifies a 560 bp variable fragment 
of the ssu rRNA gene was tested for general applicability in diagnostics. The 42 L. donovani 
complex strains and the 24 canine samples from clinical cases were processed and the 
sensitivity of this PCR was 100 %. 
 
Digestion of the ITS in combination with the fingerprinting with single arbitrary primers was 
able to distinguish the parasites to the species level and revealed strain variations within the 
species. The variations detected with PCR fingerprinting with arbitrary primers were mainly 
depending to the geographical origin of the isolates. 
 
Data analyses, which combined the results from the ITS-RFLP and fingerprinting with single 
arbitrary primers and PCR-SSCP, suggest that among the strains of L. infantum there is most 
probably a clonal mode of propagation. Nevertheless, occasional genetic exchanges can not 
be totally excluded in predominantly clonal populations. 
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7. ZUSAMMENFASSUNG 
Ziel dieser Studie war die Überprüfung der PCR als Methode zür Erfassung  und 
Identifizierung von Arten der Leishmania (incl. Viannia) sowie Bestimmung von genetischen 
Varianten in L.infantum. 
 
Züdiesem Zweck wurden insgesamt 36 gut bekannte Leishmanien-Stämme, 21 
Isolate aus nordgriechischen Hunden, 9 Isolate aus Menschen unterschiedlicher 
geographisches Herkunft und 24 Proben aus erkrankten Hunde naus Deutschland, die sich 
zuvor in Südde Europa aufgehalten hatten, untersucht. 
 
In einen ersten Serie wurde in den Probender ITS (Internally Transcribed Spacer) amplifiziert. 
Die restriktionsenzymatische verdaüng der Amplifikate mit HaeIII und CfoI. Gestattete es die 
Isolate bis auf die Ebene derArten-Komplexe und zum Teil auch auf die Ebene der Spezies zu 
charakterisieren/identifizieren (L. aethiopica, L. tropica). Die Muster, die für L. donovani-
Isolate gefunden wurden, waren fast identisch. 
 
Die Isolate wurden anschließend mit Hilfe genetischer „Fingerprints“ mittels 
willkürliche er (arbitrary)Primer getestet. Die benutzten Primer stammten aus der 
Kernsequenz des Phagen M13, des intergenetischen „tRNA genes’ spacers“ (T3B) und der 
Wiederholungssequenzen (GTG)5 und (GACA)4. Die 21 Isolate aus den Hunden 
wurden alle als L. infantum identifiziert. Aus den 9 menschlichen Proben wurden 
drei als L. tropica, jeweils eine als L. aethiopica,  
L. donovani, eine (1) als L. chagasi, eine (1) als L. brasiliensis und zwei (2) als 
L. guayanensis identifiziert. Sie alle zeigten  polymorphe Muster, die mit den 
Referenzstämmen gepaart werden konnten. Innerhalb der 
Species L. infantum wurden Untergruppen unterschieden, die hauptsächlich mit 
ünterschiedlichen geografischen Herkunft der Isolate züsammenliegen. 
 
Eine PCR-SSCP (Polymerase Chain Reaction - Single Strand Conformation 
Analysis) benutzte einen Satz aus 8 codominanten „Primer Pair“-Makern und würde zür 
untersuchung von 42 Isolaten/Stämmen aus dem  L. donovani-Komplex (38 L. infantum, 2 L. 
chagasi und 2 L. donovani) herausgezogen. Nur ein Primer Pair Maker zeigte einige 
unterschiedliche Muster in der SSCP an, die ein Isolat als L. chagasi Stamm und vier (4) als 
L. infantum Stamm identifizierte. 
 
Im Sinne eines praktischen diagnostischen Verfarens züm Nachwers von L. donovani läß sich 
für ein einfaches PCR-süchsystem, beidem ein variables 560 bp fragment des ssü rRNA-Gens 
amplifiziert wird, eine 100 % ige sensitivität zeigen, d.h. alle als L. donovani bekannten 
Identifizierten Stämme/Isolate würden erfaßt. Eine Kombination der restriktionenzymatischen 
analyse des ITS-Amplifikate mit dem genetischen „Fingerprint“ ermöglichte eine 
ünterscheidung der arten und zeigte varianten auf. Die beobachteten varianten läßen sich der 
geographischen Herkunft der Stämme/Isolate züordnen. 
 
Die Analyse der Daten ünter Einbeziehüng der Ergebnisse aus dem ITS-RFLP, dem 
genetischen „Fingerprinting“ und der PCR-SSCP läßt vermuten, 
daß es innerhalb der Art L. infantum einen klonalen Verbreitungsmodus gibt. 
Dennoch kann gelegentlicher genetischer Austausch in sonst 
hauptsächlich klonalen Populationen nicht ausgeschlossen werden. 
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